| NPU/SWE kod | Fullständigt svenskt namn IUPAC/IFCC syntax | Mätenhet | Trivialnamn |
|
| NPU01440 | Plasma—1,25-Kalcitriol;substanskoncentration | pmol/L | S--1,25 D-vitamin |
| NPU10615 | Plasma—10-Hydroxikarbamazepin;substanskoncentration | µmol/L | S--Hydroxikarbamazepin |
| NPU02460 | Plasma—17-Hydroxiprogesteron;substanskoncentration | nmol/L | S--17-Hydroxiprogesteron |
| NPU14238 | Urin—1-Metylhistidin/Kreatinin;substanskvot | x10^ -3 | U--1-Metylhistidin/Krea |
| NPU02776 | Plasma—1-Metylhistidin;substanskoncentration | µmol/L | P--1-Metylhistidin |
| NPU04927 | Urin—3,4-Metylendioxiamfetamin;arbiträr koncentration(procedur) | | U--MDA (sållning) |
| NPU04701 | Urin—3,4-Metylendioximetamfetamin;arbiträr koncentration(procedur) | | U--MDMA (sållning) |
| NPU10002 | Patient(Urin)—3-Metoxiadrenalin/Kreatinin;substansflödeskvot(procedur) | x10^-6 | Pt(U)--3-MA/Krea-uts |
| NPU10003 | Patient(Urin)—3-Metoxinoradrenalin/Kreatinin;substansflödeskvot(procedur) | x10^-6 | Pt(U)--3-MNA/Krea-uts |
| NPU10004 | Patient(Urin)—3-Metoxityramin/Kreatinin;substansflödeskvot(procedur) | x10^-6 | Pt(U)--3-MT/Krea-uts |
| NPU14239 | Urin—3-Metylhistidin/Kreatinin;substanskvot | x10^ -3 | U--3-Metylhistidin/Krea |
| NPU02778 | Plasma—3-Metylhistidin;substanskoncentration | µmol/L | P--3-Metylhistidin |
| NPU02465 | Urin—4-Hydroxiprolin;substanskoncentration | µmol/L | U--4-Hydroxiprolin |
| NPU09006 | Urin—5-Aminolevulinat/Kreatinin;substanskvot | x10^ -3 | U--5-Aminolevulinat/Krea |
| NPU04159 | Urin—5-Aminolevulinat;substanskoncentration | µmol/L | U--5-Aminolevulinat |
| NPU18372 | Urin—5-Hydroxiindolylacetat/Kreatinin;substanskvot | x10^ -3 | U--5-HIA/Kreatinin |
| NPU02430 | Urin—5-Hydroxiindolylacetat;substanskoncentration | µmol/L | U--5-HIA |
| NPU03939 | Patient(Urin)—5-Hydroxiindolylacetat;substansflöde(procedur) | µmol/d | Pt(U)--5-HIA-uts |
| NPU02433 | Plasma—5-Hydroxilysin;substanskoncentration | µmol/L | P--5-Hydroxilysin |
| NPU02926 | Plasma—5'-Nukleotidas;katalytisk koncentration(37ºC;procedur) | nkat/L | S--5´-Nukleotidas |
| NPU08927 | Urin—6-Monoacetylmorfin;arbiträr koncentration(procedur) | | U--MAM (sållning) |
| NPU04624 | Plasma—Acetazolamid;substanskoncentration | µmol/L | S--Acetazolamid |
| NPU10504 | Urin—Acetoacetat;arbiträr koncentration(procedur) | | U--Acetoacetat(remsa) |
| NPU20006 | Blod—Aceton;substanskoncentration | mmol/L | B--Aceton |
| NPU18644 | Plasma—Aceton;substanskoncentration | mmol/L | S--Aceton |
| NPU01036 | Plasma—Acetylkolinreceptorantikropp(Immunglobulin G);arbiträr substanskoncentration(procedur) | arb enh/L | S--Acetylkolinreceptor-ak |
| NPU04625 | Plasma—Adrenalin;substanskoncentration | nmol/L | P--Adrenalin |
| NPU03917 | Patient(Urin)—Adrenalin;substansflöde(procedur) | nmol/d | Pt(U)--Adrenalin-uts |
| NPU03916 | Urin—Adrenalin;substanskoncentration | nmol/L | U--Adrenalin |
| NPU10546 | Patient—Adrenalin+noradrenalin sekretion;arbiträrt flöde(klonidin oralt;lista;procedur) | | Pt--Adr+noradr-ins(kloni) |
| NPU14186 | Urin—Alanin/Kreatinin;substanskvot | x10^ -3 | U--Alanin/Kreatinin |
| NPU01117 | Plasma—Alanin;substanskoncentration | µmol/L | P--Alanin |
| NPU01116 | Cerebrospinalvätska—Alanin;substanskoncentration | µmol/L | Csv--Alanin |
| NPU01121 | Plasma—Alaninaminotransferas;katalytisk koncentration(37ºC;procedur) | µkat/L | S--ALAT |
| SWE05310 | Urin—Albumin/Kreatinin;arbiträr egenskap(procedur) | g/mol | U--Albumin/Krea index |
| SWE05315 | Seminalplasma—Albumin;masskoncentration(procedur) | mg/L | SemP--Albumin (mass) |
| SWE05024 | Urin—Albumin;arbiträr koncentration(procedur) | | U--Albumin (remsa) |
| SWE05002 | Urin—Albumin;masskoncentration(procedur) | g/L | U--Albumin (mass) |
| SWE05001 | Plasma—Albumin;masskoncentration(procedur) | g/L | S--Albumin (mass) |
| SWE05056 | Cerebrospinalvätska—Albumin;masskoncentration(procedur) | g/L | Csv--Albumin (mass) |
| SWE05152 | Ledvätska(specifikation)—Albumin;masskoncentration(procedur) | g/L | Ledv--Albumin (mass) |
| SWE05008 | Patient(Urin)—Albumin;massflöde(procedur) | g/d | Pt(U)--Albumin-uts |
| SWE05121 | Patient(Urin)—Albumin;massflöde(procedur) | µg/min | Pt(U)--Albumin(mikro)-uts |
| SWE05164 | Cerebrospinalvätska—Albumin;masskoncentration | mg/L | Csv--Albumin (mass) |
| SWE05006 | Urin—Albumin;masskoncentration | mg/L | U--Albumin (mass) |
| SWE05151 | Ascites—Albumin;masskoncentration(procedur) | g/L | Asc--Albumin (mass) |
| SWE05150 | Pleuravätska—Albumin;masskoncentration(procedur) | g/L | Pleura--Albumin (mass) |
| SWE05155 | Plasma—Albumin;masskoncentration(immunologisk;procedur) | g/L | P--Albumin(mass imm) |
| NPU04125 | Njure—Albuminclearance/Kreatininclearance;volymflödeskvot | x10^ -3 | Pt--Alb/Krea clearance |
| NPU14040 | Plasma—Aldosteron;substanskoncentration | nmol/L | S--Aldosteron |
| NPU03853 | Urin—Aldosteron;substanskoncentration | pmol/L | U--Aldosteron |
| NPU01135 | Plasma—Aldosteron;substanskoncentration | pmol/L | S--Aldosteron |
| NPU01136 | Patient(Urin)—Aldosteron;substansflöde(procedur) | nmol/d | Pt(U)--Aldosteron-uts |
| NPU02042 | Amnionvätska—alfa-1-Fetoprotein;arbiträr substanskoncentration(IS 72/225;procedur) | IE/L | Amn--alfa-1-Fetoprotein |
| SWE05010 | Plasma—alfa-1-Fetoprotein;masskoncentration | µg/L | S--alfa-1-Fetoprotein(mass) |
| SWE05313 | Amnionvätska—alfa-1-Fetoprotein;masskoncentration | mg/L | Amn--AFP (mass) |
| SWE05322 | Urin—alfa-1-Mikroglobulin/Kreatinin;arbiträr egenskap(procedur) | g/mol | U--Protein HC/Krea index |
| SWE05091 | Urin—alfa-1-Mikroglobulin;masskoncentration | g/L | U--Protein HC (mass) |
| SWE05323 | Urin—alfa-1-Mikroglobulin;masskoncentration | mg/L | U--Protein HC (mass) |
| NPU01203 | Plasma—alfa-Aminoadipat;substanskoncentration | µmol/L | P--alfa-Aminoadipat |
| NPU14191 | Urin—alfa-Aminobutyrat/Kreatinin;substanskvot | x10^ -3 | U--alfa-Aminobutyrat/Krea |
| NPU09014 | Plasma—alfa-Aminobutyrat;substanskoncentration | µmol/L | P--alfa-Aminobutyrat |
| NPU09018 | Cerebrospinalvätska—alfa-Aminobutyrat;substanskoncentration | µmol/L | Csv--alfa-Aminobutyrat |
| NPU01140 | Patient(Feces)—Alifatiskt karboxilat(C14-C26)+estrar;substansflöde(procedur) | mmol/d | Pt(F)--Fettsyre-uts |
| NPU08965 | Plasma—Alimemazin;substanskoncentration | nmol/L | S--Alimemazin |
| NPU10602 | Plasma—Alkaliskt fosfatas, 'annan' typ(specifikation);katalytisk koncentration(37ºC;procedur) | µkat/L | S--ALP, 'annan' typ |
| NPU10600 | Plasma—Alkaliskt fosfatas, lever endotelialtyp;katalytisk koncentration(37ºC;procedur) | µkat/L | S--ALP, lever endotel typ |
| NPU10601 | Plasma—Alkaliskt fosfatas, lever kanalikulärtyp;katalytisk koncentration(37ºC;procedur) | µkat/L | S--ALP, lever kanalik typ |
| NPU01013 | Plasma—Alkaliskt fosfatas, levertyp;katalytisk koncentration(37ºC;procedur) | µkat/L | S--ALP, levertyp |
| NPU01483 | Plasma—Alkaliskt fosfatas, placentatyp;katalytisk koncentration(37ºC;procedur) | µkat/L | S--ALP, placentatyp |
| NPU01145 | Plasma—Alkaliskt fosfatas, skelettyp;katalytisk koncentration(37ºC;procedur) | µkat/L | S--ALP, skelettyp |
| NPU01530 | Plasma—Alkaliskt fosfatas, tarmtyp;katalytisk koncentration(37ºC;procedur) | µkat/L | S--ALP, tarmtyp |
| NPU04589 | Plasma—Alkaliskt fosfatas, typ;katalytisk koncentration(lista;37ºC;procedur) | | S--ALP isoenzym |
| NPU01144 | Plasma—Alkaliskt fosfatas;katalytisk koncentration(37ºC;procedur) | µkat/L | S--Alkaliskt fosfatas |
| NPU01143 | Leukocyter(Blod)—Alkaliskt fosfatas;arbiträr katalytisk aktivitet(procedur) | | Lkc(B)--ALP |
| NPU01147 | Plasma—Allergenprecipiterande antikropp;arbiträr koncentration(procedur) | | S--Inhalationsallergen-ak |
| NPU04627 | Plasma—Alprazolam;substanskoncentration | nmol/L | S--Alprazolam |
| NPU01157 | Plasma—Aluminium;substanskoncentration | µmol/L | P--Aluminium |
| NPU01163 | Urin—Amfetamin;arbiträr koncentration(procedur) | | U--Amfetamin (sållning) |
| NPU01172 | Urin—Amilorid;substanskoncentration | µmol/L | U--Amilorid |
| NPU04773 | Plasma—Amilorid;substanskoncentration | µmol/L | S--Amilorid |
| NPU14178 | Urin—Aminosyror/Kreatinin;substanskvot(lista;procedur) | | U--Aminosyror/Kreatinin |
| NPU09012 | Urin—Aminosyror;substanskoncentration(lista;procedur) | | U--Aminosyror |
| NPU09011 | Plasma—Aminosyror;substanskoncentration(lista;procedur) | | P--Aminosyror |
| NPU01219 | Plasma—Amiodaron;substanskoncentration | µmol/L | S--Amiodaron |
| NPU04771 | Urin—Amitriptylin;arbiträr koncentration(procedur) | | U--Amitriptylin |
| NPU01224 | Plasma—Amitriptylin;substanskoncentration | nmol/L | P--Amitriptylin |
| NPU03927 | Plasma—Amitriptylin+Nortriptylin;substanskoncentration | nmol/L | S--Ami+Nortriptylin |
| NPU09232 | Konkrement(Urin)—Ammonium;arbiträrt innehåll(procedur) | | Konkr(U)--Ammonium |
| NPU01227 | Urin—Ammonium;substanskoncentration | µmol/L | U--Ammonium |
| NPU03928 | Plasma—Ammonium;substanskoncentration | µmol/L | P--Ammonium |
| NPU08591 | Plasma—Amylas, pankreastyp 3+4+5;katalytisk koncentration(37ºC;procedur) | µkat/L | S--Pankreasamylas |
| NPU08969 | Urin—Amylas, pankreastyp 3+4+5;katalytisk koncentration(37ºC;procedur) | µkat/L | U--Pankreasamylas |
| NPU03923 | Plasma—Amylas, salivtyp;katalytisk koncentration(37ºC;procedur) | µkat/L | S--Salivamylas |
| NPU01239 | Urin—Amylas;katalytisk koncentration(37ºC;procedur) | µkat/L | U--Amylas |
| NPU01238 | Plasma—Amylas;katalytisk koncentration(37ºC;procedur) | µkat/L | S--Amylas, total |
| NPU01242 | Plasma—Amylastyp;katalytisk koncentration(lista;37ºC;procedur) | | S--Amylas isoenzym |
| NPU04763 | Urin—Anabol steroid;taxon(IOC Sållning) | | U--Anabola steroider |
| NPU01253 | Plasma—Androstendion;substanskoncentration | nmol/L | S--Androstendion |
| SWE05053 | Plasma—Angiotensin I konverterande enzym;arbiträr katalytisk aktivitet(37ºC;procedur) | arb enh/L | S--ACE |
| NPU01257 | Plasma—Angiotensin;substanskoncentration | pmol/L | P--Angiotensin II |
| NPU01267 | Plasma—Anserin;substanskoncentration | µmol/L | P--Anserin |
| NPU12874 | Njure—Antidiuretisk effekt;arbiträr egenskap(desmopressin nasalt;lista;procedur) | | Pt--Desmopressintest |
| NPU08952 | Plasma—Antitrombin;relativ substanskoncentration(koagulation;aktuell/normal;procedur) | | P--Antitrombin (koag) |
| NPU10007 | Plasma—Antitrombin;arbiträr substanskoncentration(enzymatisk;IS 93/768;procedur) | kIE/L | P--Antitrombin (enz) |
| SWE05009 | Plasma—Antitrypsin;masskoncentration | g/L | P--Antitrypsin (mass) |
| NPU10618 | Plasma—Antitrypsintyp;taxon(procedur) | | P--Pi- typning |
| SWE05086 | Plasma—Apolipoprotein A1;masskoncentration | g/L | P--ApolipoproteinA1(mass) |
| NPU10238 | Plasma—Apolipoprotein B/Apolipoprotein A1;substanskvot | | S--Apo B/Apo A1 (kvot) |
| SWE05087 | Plasma—Apolipoprotein B;masskoncentration | g/L | P--Apolipoprotein B(mass) |
| SWE05083 | Plasma—Apolipoprotein Lp(a);masskoncentration | mg/L | P--Apolipopr Lp(a) (mass) |
| NPU14196 | Urin—Arginin/Kreatinin;substanskvot | x10^ -3 | U--Arginin/Kreatinin |
| NPU01297 | Cerebrospinalvätska—Arginin;substanskoncentration | µmol/L | Csv--Arginin |
| NPU01298 | Plasma—Arginin;substanskoncentration | µmol/L | P--Arginin |
| NPU01317 | Plasma—Askorbat;substanskoncentration | µmol/L | P--Askorbat |
| NPU14198 | Urin—Asparagin/Kreatinin;substanskvot | x10^ -3 | U--Asparagin/Kreatinin |
| NPU01318 | Cerebrospinalvätska—Asparagin;substanskoncentration | µmol/L | Csv--Asparagin |
| NPU01319 | Plasma—Asparagin;substanskoncentration | µmol/L | P--Asparagin |
| NPU14199 | Urin—Aspartat/Kreatinin;substanskvot | x10^ -3 | U--Aspartat/Kreatinin |
| NPU01322 | Plasma—Aspartat;substanskoncentration | µmol/L | P--Aspartat |
| NPU01321 | Cerebrospinalvätska—Aspartat;substanskoncentration | µmol/L | Csv--Aspartat |
| NPU01324 | Plasma—Aspartataminotransferas;katalytisk koncentration(37ºC;procedur) | µkat/L | S--ASAT |
| NPU14005 | Urin—Atrium natriuretisk peptid;substanskoncentration | pmol/L | U--ANP |
| NPU14006 | Patient(Urin)—Atrium natriuretisk peptid;substansflöde | pmol/d | Pt(U)--ANP-utsöndring |
| NPU01338 | Plasma(arteriellt Blod)—Atrium natriuretisk peptid;substanskoncentration | pmol/L | P(aB)--ANP |
| NPU10506 | Urin—Bakterie, nitritproducerande;arbiträr koncentration(procedur) | | U--Bakterie,nitrit(remsa) |
| NPU08592 | Urin—Bakterie;arbiträr koncentration(procedur) | | U--Bakterie (remsa) |
| NPU18631 | Urin—Bakterie;arbiträrt antal(procedur) | arb enh | U--Bakterie (antal) |
| NPU08959 | Urin—Barbiturat(total);arbiträr koncentration(procedur) | | U--Barbiturater |
| NPU01345 | Plasma—Barbiturat;taxon(procedur) | | S--Barbiturat |
| NPU01349 | Blod—Basofila granulocyter;antalskoncentration | x10^9/L | B--Basofila granulocyter |
| NPU03968 | Leukocyter(Blod)—Basofila granulocyter;antalsfraktion | | Lkc(B)--Basofila granulo |
| NPU12520 | Plasma(kapillärt Blod)—Basöverskott;substanskoncentration(aktuell-normal) | mmol/L | P(kB)--Basöverskott |
| NPU12521 | Plasma(venöst Blod)—Basöverskott;substanskoncentration(aktuell-normal) | mmol/L | P(vB)--Basöverskott |
| NPU12518 | Plasma(arteriellt Blod)—Basöverskott;substanskoncentration(aktuell-normal) | mmol/L | P(aB)--Basöverskott |
| NPU01351 | Urin—Bence Jones' protein;arbiträr koncentration(procedur) | | U--Bence Jones protein |
| NPU01359 | Plasma—Bensodiazepin;substanskoncentration(procedur) | nmol/L | S--Bensodiazepin |
| NPU17591 | Plasma—Bensodiazepiner;arbiträr koncentration(procedur) | | S--Bensodiazepiner(sålln) |
| NPU04827 | Urin—Bensodiazepiner;arbiträr koncentration(lista;procedur) | | U--Bensodiazep(såll,list) |
| NPU08958 | Urin—Bensodiazepiner;arbiträr koncentration(procedur) | | U--Bensodiazepiner(sålln) |
| NPU04062 | Urin—Bensodiazepiner;taxon(procedur) | | U--Bensodiazepiner |
| NPU08994 | Urin—Bensoylekgonin;arbiträr koncentration(procedur) | | U--Bensoylekgonin (sålln) |
| SWE05034 | Plasma—beta-2-Mikroglobulin;masskoncentration | mg/L | P--beta2-Mikroglob(mass) |
| NPU01119 | Plasma—beta-Alanin;substanskoncentration | µmol/L | P--beta-Alanin |
| NPU14193 | Urin—beta-Aminoisobutyrat/Kreatinin;substanskvot | x10^ -3 | U--beta-Aminoisobuty/Krea |
| NPU01207 | Plasma—beta-Aminoisobutyrat;substanskoncentration | µmol/L | P--beta-Aminoisobutyrat |
| NPU10606 | Plasma—beta-Endorfin;substanskoncentration | pmol/L | P--beta-Endorfin |
| NPU01370 | Plasma—Bilirubiner(total);substanskoncentration | µmol/L | S--Bilirubin, total |
| NPU01372 | Urin—Bilirubiner(total);arbiträr koncentration(procedur) | | U--Bilirubin, total |
| NPU01368 | Plasma—Bilirubinglukuronid;substanskoncentration | µmol/L | S--Bilirubin, konjugerat |
| NPU01379 | Plasma—Biotinidas;katalytisk koncentration(37ºC;procedur) | nkat/L | S--Biotinidas |
| NPU03972 | Blod—Blastceller;antalskoncentration | x10^9/L | B--Blastceller |
| NPU03971 | Leukocyter(Blod)—Blastceller;antalsfraktion | | Lkc(B)--Blastceller |
| NPU02572 | Blod—Bly;substanskoncentration | µmol/L | B--Bly |
| NPU02575 | Urin—Bly;substanskoncentration | µmol/L | U--Bly |
| NPU17181 | Plasma—Brain natriuretic peptide;substanskoncentration | pmol/L | P--BNP |
| NPU04349 | Plasma—Buspiron;substanskoncentration | nmol/L | S--Buspiron |
| NPU03929 | Urin—Calcium(II, total)/Kreatinin;substanskvot | | U--Calcium/Kreatinin |
| NPU09230 | Konkrement(Urin)—Calcium(II, total);arbiträrt innehåll(procedur) | | Konkr(U)--Calcium, total |
| NPU17172 | Dialysvätska(specifikation)—Calcium(II, total);substanskoncentration | mmol/L | Dv(spec)--Calcium, total |
| NPU01443 | Plasma—Calcium(II, total);substanskoncentration | mmol/L | S--Calcium, total |
| NPU01442 | Patient(Urin)—Calcium(II, total);substansflöde(procedur) | mmol/d | Pt(U)--Calcium-uts |
| NPU04160 | Urin—Calcium(II, total);substanskoncentration | mmol/L | U--Calcium, total |
| NPU04169 | Plasma—Calcium(II, total);substanskoncentration(korrigerat) | mmol/L | S--Calcium, total (korr) |
| NPU10366 | Konkrement(Urin)—Calciumfosfat;arbiträrt innehåll(procedur) | | Konkr(U)--Calciumfosfat |
| NPU01446 | Plasma—Calciumjon(fritt);substanskoncentration | mmol/L | S--Calciumjon, fri |
| NPU04144 | Plasma—Calciumjon(fritt);substanskoncentration(pH 7,40;procedur) | mmol/L | S--Calciumjon, fri(pH7,4) |
| NPU10364 | Konkrement(Urin)—Calciumkarbonat;arbiträrt innehåll(procedur) | | Konkr(U)--Calciumkarbonat |
| NPU01445 | Konkrement(Urin)—Calciumkarbonat;substansinnehåll | mol/kg | Konkr(U)--Calciumkarbonat |
| NPU01447 | Konkrement(Urin)—Calciumoxalat;substansinnehåll | mol/kg | Konkr(U)--Calciumoxalat |
| NPU10365 | Konkrement(Urin)—Calciumoxalat;arbiträrt innehåll(procedur) | | Konkr(U)--Calciumoxalat |
| NPU01448 | Plasma—Cancerantigen 125;arbiträr substanskoncentration(procedur) | x10^3 arb enh/L | P--Cancerantigen 125 |
| NPU01449 | Plasma—Cancerantigen 15-3;arbiträr substanskoncentration(procedur) | x10^3 arb enh/L | S--Cancerantigen 15-3 |
| NPU01450 | Plasma—Cancerantigen 19-9;arbiträr substanskoncentration(procedur) | x10^3 arb enh/L | S--Cancerantigen 19-9 |
| NPU01451 | Plasma—Cancerantigen 50;arbiträr substanskoncentration(procedur) | x10^3 arb enh/L | S--Cancerantigen 50 |
| NPU18371 | Plasma—Cancerantigen 72-4;arbiträr substanskoncentration(procedur) | x10^3 arb enh/L | S--Cancerantigen 72-4 |
| NPU04135 | Cerebrospinalvätska—Celltyp;antalskoncentration(lista;procedur) | | Csv--Celler |
| SWE05123 | Plasma—Ceruloplasmin;masskoncentration | g/L | P--Ceruloplasmin (mass) |
| SWE05061 | Blod—Ciklosporin;masskoncentration | µg/L | B--Cyklosporin (mass) |
| NPU04778 | Plasma—Citalopram;substanskoncentration | nmol/L | S--Citalopram |
| NPU14204 | Urin—Citrullin/Kreatinin;substanskvot | x10^ -3 | U--Citrullin/Kreatinin |
| NPU01611 | Plasma—Citrullin;substanskoncentration | µmol/L | P--Citrullin |
| NPU09020 | Cerebrospinalvätska—Citrullin;substanskoncentration | µmol/L | Csv--Citrullin |
| SWE05027 | Plasma—C-reaktivt protein;masskoncentration | mg/L | P--CRP (mass) |
| NPU04780 | Blod—Cyanid;substanskoncentration | µmol/L | B--Cyanid |
| NPU01817 | Urin—Cylinder, erytrocyttyp;arbiträr koncentration(procedur) | | U--Cylinder, erytrocyttyp |
| NPU18632 | Urin—Cylinder, erytrocyttyp;arbiträrt antal(procedur) | arb enh | U--Cylinder, erc (ant) |
| NPU18633 | Urin—Cylinder, granulartyp;arbiträrt antal(procedur) | arb enh | U--Cylinder, gran (ant) |
| NPU01818 | Urin—Cylinder, granulartyp;arbiträr koncentration(procedur) | | U--Cylinder, granulartyp |
| NPU01819 | Urin—Cylinder, hyalintyp;arbiträr koncentration(procedur) | | U--Cylinder, hyalintyp |
| NPU18634 | Urin—Cylinder, hyalintyp;arbiträrt antal(procedur) | arb enh | U--Cylinder, hyalin (ant) |
| NPU18911 | Urin—Cylinder, leukocyttyp;arbiträrt antal(procedur) | arb enh | U--Cylinder, lkc (ant) |
| SWE05137 | Plasma—Cystatin C;masskoncentration | mg/L | S--Cystatin C |
| NPU01820 | Plasma—Cystationin;substanskoncentration | µmol/L | P--Cystationin |
| NPU09007 | Urin—Cysteinyldopa/Kreatinin;substanskvot | x10^-6 | U--Cysteinyldopa/Krea |
| NPU14207 | Urin—Cystin/Kreatinin;substanskvot | x10^ -3 | U--Cystin/Kreatinin |
| NPU10367 | Konkrement(Urin)—Cystin;arbiträrt innehåll(procedur) | | Konkr(U)--Cystin |
| NPU04161 | Patient(Urin)—Cystin;substansflöde(procedur) | µmol/d | Pt(U)--Cystin-uts |
| NPU09021 | Cerebrospinalvätska—Cystin;substanskoncentration | µmol/L | Csv--Cystin |
| NPU01828 | Urin—Cystin;substanskoncentration | µmol/L | U--Cystin |
| NPU04782 | Urin—Cystin;arbiträr koncentration(procedur) | | U--Cystin (kval) |
| NPU01826 | Plasma—Cystin;substanskoncentration | µmol/L | P--Cystin |
| NPU01852 | Plasma—Dehydroepiandrosteron;substanskoncentration | nmol/L | S--Dehydroepiandrosteron |
| NPU04121 | Plasma—Dehydroepiandrosteronsulfat;substanskoncentration | µmol/L | S--DHEAS |
| NPU01856 | Plasma—Deoxikortisol;substanskoncentration | nmol/L | S--Deoxikortisol |
| NPU09098 | Urin—Deoxipyridinolin/Kreatinin;substanskvot | x10^-6 | U--Deoxipyridinolin/Krea |
| NPU08618 | Plasma—Desetylamiodaron;substanskoncentration | µmol/L | S--Desetylamiodaron |
| NPU01858 | Plasma—Desipramin;substanskoncentration | nmol/L | S--Desipramin |
| NPU14067 | Plasma—Desmetylklomipramin;substanskoncentration | nmol/L | S--Desmetylklomipramin |
| NPU01866 | Urin—Dextropropoxifen;arbiträr koncentration(procedur) | | U--Dextropropoxif (sålln) |
| NPU01863 | Plasma—Dextropropoxifen;substanskoncentration | µmol/L | S--Dextropropoxifen |
| NPU01879 | Plasma—Diazepam;substanskoncentration | µmol/L | S--Diazepam |
| NPU01880 | Urin—Diazepam;arbiträr koncentration(procedur) | | U--Diazepam (sållning) |
| NPU04786 | Plasma—Digitoxin;substanskoncentration | nmol/L | P--Digitoxin |
| NPU01886 | Plasma—Digoxin;substanskoncentration | nmol/L | S--Digoxin |
| NPU01912 | Plasma—Disopyramid;substanskoncentration | µmol/L | S--Disopyramid |
| NPU01264 | Plasma—Djur-hår+epitel-antikropp(Immunglobulin E);arbiträr koncentration(lista;NCCLS/e;procedur) | | S--Djurepitel-ak (IgE) |
| NPU14175 | Patient(Urin)—Dopamin;substansflöde | nmol/d | Pt(U)--Dopamin-uts |
| NPU14174 | Urin—Dopamin;substanskoncentration | nmol/L | U--Dopamin |
| NPU03967 | Leukocyter(Blod)—Eosinofila granulocyter;antalsfraktion | | Lkc(B)--Eosinofila gran |
| NPU17562 | Blod—Eosinofila granulocyter;antalskoncentration | x10^9/L | B--Eosinofila gran (mikr) |
| NPU18282 | Blod—Eosinofila granulocyter;antalskoncentration | x10^9/L | B--Eosinofila gran (mask) |
| NPU01934 | Sputum—Eosinofila granulocyter;arbiträr koncentration(procedur) | | Sputum--Eosinofila gran |
| NPU01933 | Blod—Eosinofila granulocyter;antalskoncentration | x10^9/L | B--Eosinofila granulocyter |
| NPU18635 | Urin—Epitelceller;arbiträrt antal | arb enh | U--Epitelceller (antal) |
| NPU04690 | Blod—Erytroblaster(basofil);antalskoncentration | x10^9/L | B--Erytroblaster, basofil |
| NPU04692 | Blod—Erytroblaster(ortokrom);antalskoncentration | x10^9/L | B--Erytroblaster,ortokrom |
| NPU04695 | Blod—Erytroblaster(polykrom);antalskoncentration | x10^9/L | B--Erytroblaster,polykrom |
| NPU10143 | Leukocyter(Blod)—Erytroblaster;antalsfraktion | | Lkc(B)--Erytroblaster |
| NPU01943 | Blod—Erytroblaster;antalskoncentration | x10^9/L | B--Erytroblaster |
| SWE05314 | Blod—Erytroblaster;arbiträr egenskap(procedur) | | B--Erytroblaster |
| NPU14259 | Blod—Erytrocyter(Anisocytos);arbiträr koncentration(procedur) | | B--Erytrocyter,anisocytos |
| NPU03963 | Urin—Erytrocyter;arbiträr koncentration(procedur) | | U--Erytrocyter (remsa) |
| NPU04221 | Blod—Erytrocyter;morfologi(procedur) | | B--Erytrocyter, morfologi |
| NPU01961 | Blod—Erytrocyter;volymfraktion | | B--EVF |
| NPU01960 | Blod—Erytrocyter;antalskoncentration | x10^12/L | B--Erytrocyter |
| NPU01944 | Blod—Erytrocyter;entitisk volym | fL | B--MCV |
| NPU01962 | Cerebrospinalvätska—Erytrocyter;antalskoncentration | x10^6/L | Csv--Erytrocyter |
| NPU08967 | Amnionvätska—Erytrocyter;antalskoncentration | x10^6/L | Amn--Erytrocyter |
| NPU18636 | Urin—Erytrocyter;arbiträrt antal(procedur) | arb enh | U--Erytrocyter (antal) |
| NPU01945 | Erytrocyter(Blod)—Erytrocyttyp;taxon(AB0, Rhesus;procedur) | | Blodgruppering |
| NPU04012 | Plasma—Erytropoietin;arbiträr substanskoncentration(one-site immunoassay;IRP 67/343;procedur) | IE/L | S--Erytropoietin |
| NPU01992 | Plasma—Etanol;substanskoncentration | mmol/L | S--Etanol |
| NPU18970 | Blod—Etanol;substanskoncentration | mmol/L | B--Etanol |
| NPU01993 | Urin—Etanol;substanskoncentration | mmol/L | U--Etanol |
| NPU01994 | Plasma—Etanolamin;substanskoncentration | µmol/L | P--Etanolamin |
| NPU01999 | Plasma—Etosuximid;substanskoncentration | µmol/L | S--Etosuximid |
| NPU09008 | Plasma—Etylenglykol;substanskoncentration | mmol/L | S--Etylenglykol |
| NPU04464 | Urin—Etylmorfin;arbiträr koncentration(procedur) | | U--Etylmorfin (sållning) |
| NPU03062 | Plasma—Fenobarbital;substanskoncentration | µmol/L | S--Fenobarbital |
| NPU14241 | Urin—Fenylalanin/Kreatinin;substanskvot | x10^ -3 | U--Fenylalanin/Kreatinin |
| NPU03070 | Plasma—Fenylalanin;substanskoncentration | µmol/L | P--Fenylalanin |
| NPU03069 | Cerebrospinalvätska—Fenylalanin;substanskoncentration | µmol/L | Csv--Fenylalanin |
| NPU08971 | Plasma—Fenytoin(fritt);substanskoncentration | µmol/L | S--Fenytoin, fritt |
| NPU03085 | Plasma—Fenytoin(total);substanskoncentration | µmol/L | S--Fenytoin, total |
| SWE05012 | Plasma—Ferritin;masskoncentration | µg/L | S--Ferritin |
| NPU02037 | Leukocytprotein—Ferrokelatas;katalytiskt innehåll(37ºC;procedur) | µkat/kg | Lkc prot--Ferrokelatas |
| SWE05096 | Plasma—Fibrin D-dimer;masskoncentration(immunologisk;procedur) | mg/L | P--D-dimer |
| NPU02046 | Plasma—Fibrinfragment+Fibrinogenfragment;arbiträr substanskoncentration(immunologisk;procedur) | arb enh/L | S--FDP |
| NPU14105 | Plasma—Fibrinmonomer;arbiträr koncentration(procedur) | | P--Fibrinmonomer(kval) |
| NPU14106 | Plasma—Fibrinmonomer;substanskoncentration | nmol/L | P--Fibrinmonomer |
| SWE05063 | Plasma—Fibrinogen;masskoncentration(immunologisk;procedur) | g/L | P--Fibrinogen (imm) |
| SWE05130 | Plasma—Fibrinogen;masskoncentration(koagulation;procedur) | g/L | P--Fibrinogen (koag) |
| NPU02052 | Plasma—Fibrinopeptid A;substanskoncentration(immunologisk;procedur) | nmol/L | P--Fibrinopeptid A (imm) |
| NPU02057 | Plasma—Fibronektin;substanskoncentration | µmol/L | P--Fibronektin |
| NPU02078 | Plasma—Fisk-antikropp;arbiträr koncentration(lista;NCCLS/f;procedur) | | S--Fisk-ak |
| NPU02059 | Plasma—Flekainid;substanskoncentration | µmol/L | S--Flekainid |
| SWE05082 | Plasma—Flucytosin;masskoncentration | mg/L | S--Flucytosin |
| NPU04790 | Plasma—Flufenazin;substanskoncentration | nmol/L | S--Flufenazin |
| NPU04795 | Plasma—Flunitrazepam;substanskoncentration | nmol/L | S--Flunitrazepam |
| NPU02062 | Urin—Flunitrazepam;arbiträr koncentration(procedur) | | U--Flunitrazepam (sålln) |
| NPU08790 | Plasma—Fluoxetin;substanskoncentration | nmol/L | S--Fluoxetin |
| NPU04797 | Plasma—Flupentixol;substanskoncentration | nmol/L | S--Flupentixol |
| NPU04117 | Plasma—Fluvoxamin;substanskoncentration | nmol/L | S--Fluvoxamin |
| NPU02070 | Plasma—Folat;substanskoncentration | nmol/L | S--Folat |
| NPU02071 | Erytrocyter(Blod)—Folater(total);substanskoncentration | nmol/L | Erc(B)--Folat, total |
| NPU14326 | Blod—Folater(total);substanskoncentration | nmol/L | B--Folat, total |
| NPU04014 | Plasma—Follitropin;arbiträr substanskoncentration(IRP 78/549;procedur) | IE/L | S--Follitropin |
| NPU10570 | Hypofys—Follitropinsekretion;arbiträrt flöde(gonadorelin intravenöst;lista;procedur) | | Hf--Follitropin-ins(GnRH) |
| NPU09233 | Konkrement(Urin)—Fosfat(P, oorganiskt);arbiträrt innehåll(procedur) | | Konkr(U)--Fosfat |
| NPU03955 | Urin—Fosfat(P, oorganiskt);substanskoncentration | mmol/L | U--Fosfat |
| NPU18375 | Dialysvätska(specifikation)—Fosfat(P, oorganiskt);substanskoncentration | mmol/L | Dv(spec)--Fosfat |
| NPU03096 | Plasma—Fosfat(P, oorganiskt);substanskoncentration | mmol/L | S--Fosfat |
| NPU03095 | Patient(Urin)—Fosfat(P, oorganiskt);substansflöde(procedur) | mmol/d | Pt(U)--Fosfat-uts |
| NPU03114 | Plasma—Fosfoetanolamin;substanskoncentration | µmol/L | P--Fosfoetanolamin |
| NPU10399 | Plasma—Fosfoserin;substanskoncentration | µmol/L | P--Fosfoserin |
| NPU02097 | Seminalplasma—Fruktos;substanskoncentration | mmol/L | SemP--Fruktos |
| NPU02096 | Plasma—Fruktosamin;substanskoncentration | µmol/L | S--Fruktosamin |
| NPU03593 | Plasma—Födoämnesallergen-antikropp(Immunglobulin E);arbiträr koncentration(lista;NCCLS/f;procedur) | | S--Födoämnes-ak (IgE) |
| NPU10155 | Plasma—Gabapentin;substanskoncentration | µmol/L | S--Gabapentin |
| NPU10611 | Blod(kapillärt Blod)—Galaktos;substanskoncentration | mmol/L | B(kB)--Galaktos |
| NPU08697 | Patient—Galaktos+Glukostolerans;arbiträr egenskap(galaktos+glukos oralt;lista;procedur) | | Pt--Galak+Glukos tolerans |
| NPU10336 | Patient—Galaktostolerans;arbiträr egenskap(galaktos intravenöst;lista;procedur) | | Pt--Galaktoselimination |
| NPU10607 | Plasma(fastande Patient)—Gallsalt;substanskoncentration | µmol/L | S(fPt)--Gallsyror |
| NPU10401 | Plasma—gamma-Aminoisobutyrat;substanskoncentration | µmol/L | P--gamma-Aminoisobutyrat |
| NPU02251 | Plasma—gamma-Glutamyltransferas;katalytisk koncentration(37ºC;procedur) | µkat/L | S--GT |
| NPU14003 | Urin—Gastrin;substanskoncentration | pmol/L | U--Gastrin |
| NPU14004 | Patient(Urin)—Gastrin;substansflöde | pmol/d | Pt(U)--Gastrinutsöndring |
| NPU04152 | Plasma(fastande Patient)—Gastrin;substanskoncentration | pmol/L | P(fPt)--Gastrin |
| NPU02163 | Plasma—Gastrinfrisättande polypeptid;substanskoncentration | pmol/L | P--GRP |
| NPU04799 | Plasma—Glibenklamid;substanskoncentration | mol/L | P--Glibenklamid |
| NPU02169 | Plasma—Glukagon(total);substanskoncentration | pmol/L | P--Glukagon |
| NPU02187 | Blod—Glukos;substanskoncentration | mmol/L | B--Glukos |
| NPU08972 | Blod(fastande Patient)—Glukos;substanskoncentration | mmol/L | B(fPt)--Glukos |
| NPU02190 | Cerebrospinalvätska—Glukos;substanskoncentration | mmol/L | Csv--Glukos |
| NPU04207 | Urin—Glukos;arbiträr koncentration(procedur) | | U--Glukos (remsa) |
| NPU10052 | Blod(kapillärt Blod)—Glukos;substanskoncentration(150 minuter efter stimulering) | mmol/L | B(kB)--Glukos (150 min) |
| NPU10044 | Blod(kapillärt Blod)—Glukos;substanskoncentration(180 minuter efter stimulering) | mmol/L | B(kB)--Glukos (180 min) |
| NPU10053 | Blod(kapillärt Blod)—Glukos;substanskoncentration(210 minuter efter stimulering) | mmol/L | B(kB)--Glukos (210 min) |
| NPU10054 | Blod(kapillärt Blod)—Glukos;substanskoncentration(240 minuter efter stimulering) | mmol/L | B(kB)--Glukos (240 min) |
| NPU10051 | Blod(kapillärt Blod)—Glukos;substanskoncentration(120 minuter efter stimulering) | mmol/L | B(kB)--Glukos (120 min) |
| NPU10059 | Blod(kapillärt Blod)—Glukos;substanskoncentration(15 minuter efter stimulering) | mmol/L | B(kB)--Glukos (15 min) |
| NPU08622 | Ledvätska(specifikation)—Glukos;substanskoncentration | mmol/L | Ledv--Glukos |
| NPU10114 | Blod(kapillärt Blod)—Glukos;substanskoncentration(procedur) | mmol/L | B(kB)--Glukos |
| NPU02194 | Urin—Glukos;substanskoncentration(procedur) | mmol/L | U--Glukos (semikvant) |
| NPU10115 | Pleuravätska(specifikation)—Glukos;substanskoncentration | mmol/L | Pleura--Glukos |
| NPU10047 | Blod(kapillärt Blod)—Glukos;substanskoncentration(0 minuter efter stimulering) | mmol/L | B(kB)--Glukos (0 min) |
| NPU04093 | Blod(venöst Blod)—Glukos;substanskoncentration | mmol/L | B(vB)--Glukos |
| NPU02192 | Plasma—Glukos;substanskoncentration | mmol/L | P--Glukos |
| NPU02188 | Blod(kapillärt Blod;fastande Patient)—Glukos;substanskoncentration | mmol/L | B(kB,fPt)--Glukos |
| NPU10061 | Blod(kapillärt Blod)—Glukos;substanskoncentration(75 minuter efter stimulering) | mmol/L | B(kB)--Glukos (75 min) |
| NPU02193 | Plasma(kapillärt Blod;fastande Patient)—Glukos;substanskoncentration | mmol/L | P(kB,fPt)--Glukos |
| NPU10050 | Blod(kapillärt Blod)—Glukos;substanskoncentration(90 minuter efter stimulering) | mmol/L | B(kB)--Glukos (90 min) |
| NPU02195 | Plasma(venöst Blod;fastande Patient)—Glukos;substanskoncentration | mmol/L | P(vB,fPt)--Glukos |
| NPU03936 | Urin—Glukos;substanskoncentration | mmol/L | U--Glukos |
| NPU02191 | Patient(Urin)—Glukos;substansflöde(procedur) | mmol/d | Pt(U)--Glukosutsöndring |
| NPU10112 | Dialysvätska(specifikation)—Glukos;substanskoncentration | mmol/L | Dv(spec)--Glukos |
| NPU10048 | Blod(kapillärt Blod)—Glukos;substanskoncentration(30 minuter efter stimulering) | mmol/L | B(kB)--Glukos (30 min) |
| NPU10060 | Blod(kapillärt Blod)—Glukos;substanskoncentration(45 minuter efter stimulering) | mmol/L | B(kB)--Glukos (45 min) |
| NPU10045 | Blod(kapillärt Blod)—Glukos;substanskoncentration(60 minuter efter stimulering) | mmol/L | B(kB)--Glukos (60 min) |
| NPU02206 | Erytrocyter(Blod)—Glukos-6-fosfat 1-dehydrogenas;entitisk katalytisk aktivitet(37ºC;procedur) | akat | Erc(B)--G- 6- PD |
| NPU02196 | Patient—Glukostolerans;arbiträr egenskap(glukos oralt;lista;procedur) | | Pt--Glukostolerans |
| NPU14209 | Urin—Glutamat/Kreatinin;substanskvot | x10^ -3 | U--Glutamat/Kreatinin |
| NPU02229 | Plasma—Glutamat;substanskoncentration | µmol/L | P--Glutamat |
| NPU02228 | Cerebrospinalvätska—Glutamat;substanskoncentration | µmol/L | Csv--Glutamat |
| NPU12544 | Plasma—Glutamatdekarboxilas(gad65) antikropp(Immunglobulin G);arbiträr koncentration(procedur) | | P--GAD-ak |
| NPU14210 | Urin—Glutamin/Kreatinin;substanskvot | x10^ -3 | U--Glutamin/Kreatinin |
| NPU02249 | Plasma—Glutamin;substanskoncentration | µmol/L | P--Glutamin |
| NPU09022 | Cerebrospinalvätska—Glutamin;substanskoncentration | µmol/L | Csv--Glutamin |
| NPU04801 | Erytrocyter(Blod)—Glutationperoxidas;entitisk katalytisk aktivitet(37ºC;procedur) | akat | Erc(B)--Glutationperoxidas |
| NPU08973 | Plasma—Glycerol;substanskoncentration | mmol/L | S--Glycerol |
| NPU14211 | Urin—Glycin/Kreatinin;substanskvot | x10^ -3 | U--Glycin/Kreatinin |
| NPU02289 | Plasma—Glycin;substanskoncentration | µmol/L | P--Glycin |
| NPU02288 | Cerebrospinalvätska—Glycin;substanskoncentration | µmol/L | Csv--Glycin |
| NPU18612 | Blod—Granulocyter;antalskoncentration | x10^9/L | B--Granulocyter |
| NPU18611 | Leukocyter(Blod)—Granulocyter;antalsfraktion | | Lkc(B)--Granulocyter |
| NPU04803 | Plasma—Griseofulvin;substanskoncentration | mol/L | S--Griseofulvin |
| NPU03207 | Plasma—Gräspollen-antikropp(Immunglobulin E);arbiträr koncentration(lista;NCCLS/g;procedur) | | S--Gräspollen-ak (IgE) |
| NPU03937 | Plasma—Haloperidol;substanskoncentration | nmol/L | S--Haloperidol |
| SWE05019 | Plasma—Haptoglobin;masskoncentration | g/L | P--Haptoglobin (mass) |
| NPU03835 | Hemoglobin(Fe;Blod)—Hemoglobin A1c(Fe);substansfraktion | | Hb(B)--Hemoglobin A1c |
| NPU04611 | Hemoglobin(Fe;Blod)—Hemoglobin A2(Fe);substansfraktion | | Hb(B)--Hemoglobin A2 |
| NPU04613 | Hemoglobin(Fe;Blod)—Hemoglobin F(Fe);substansfraktion | | Hb(B)--Hemoglobin F |
| NPU09034 | Hemoglobin(Fe;Blod)—Hemoglobin, värmeinstabilt(Fe);arbiträr koncentration(procedur) | | Hb(B)--Hb, instabilt |
| SWE05074 | Blod—Hemoglobin;masskoncentration | g/L | B--Hemoglobin (mass) |
| SWE05129 | Erytrocyter(Blod)—Hemoglobin;entitisk massa | pg | Erc(B)--MCH |
| SWE05128 | Erytrocyter(Blod)—Hemoglobin;masskoncentration | g/L | Erc(B)--MCHC (mass) |
| NPU01393 | Feces—Hemoglobin;arbiträrt innehåll(procedur) | | F--Hemoglobin (remsa) |
| NPU04208 | Urin—Hemoglobin;arbiträr koncentration(procedur) | | U--Hemoglobin (remsa) |
| NPU02326 | Hemoglobin(Blod)—Hemoglobintyp;substansfraktion(lista;procedur) | | Hb(B)--Hemoglobinfrakt |
| NPU17703 | Hemoglobin(Blod)—Hemoglobintyp;arbiträr egenskap(lista;procedur) | | Hb(B)--Hemoglobintyper |
| NPU04209 | Urin—Hemosiderin;arbiträr koncentration(procedur) | | U--Hemosiderin |
| NPU02343 | Plasma—Heparin, lågmolarmassa;arbiträr substanskoncentration(enzymatisk;IS 85/600;procedur) | kIE/L | P--Heparin, LM |
| NPU14391 | Plasma—Heparin;arbiträr substanskoncentration(enzymatisk;IS 82/502;procedur) | kIE/L | P--Heparin (enz) |
| NPU02340 | Plasma—Heparin;arbiträr substanskoncentration(enzymatisk;IS 82/502;procedur) | IE/L | P--Heparin (enz) |
| NPU04805 | Blod—Histamin;substanskoncentration | µmol/L | B--Histamin |
| NPU04812 | Patient(Urin)—Histamin;substansflöde(procedur) | µmol/d | Pt(U)--Histamin-uts |
| NPU14213 | Urin—Histidin/Kreatinin;substanskvot | x10^ -3 | U--Histidin/Kreatinin |
| NPU09023 | Cerebrospinalvätska—Histidin;substanskoncentration | µmol/L | Csv--Histidin |
| NPU02373 | Plasma—Histidin;substanskoncentration | µmol/L | P--Histidin |
| NPU04073 | Plasma—Homocystein(total);substanskoncentration | µmol/L | P--Homocystein, total |
| NPU14217 | Urin—Homocystin/Kreatinin;substanskvot | x10^ -3 | U--Homocystin/Kreatinin |
| NPU02397 | Plasma—Homocystin;substanskoncentration | µmol/L | P--Homocystin |
| NPU10164 | Urin—Homovanillat/Kreatinin;substanskvot | x10^ -3 | U--Homovanillat/Kreatinin |
| NPU02402 | Urin—Homovanillat;substanskoncentration | µmol/L | U--Homovanillat |
| NPU04814 | Patient(Urin)—Homovanillat;substansflöde(procedur) | µmol/d | Pt(U)--Homovanillat-uts |
| NPU04693 | Urin—Hydromorfon;arbiträr koncentration(procedur) | | U--Hydromorfon (sållning) |
| NPU02462 | Patient(Urin)—Hydroxiprolin(fritt);substansflöde(procedur) | µmol/d | Pt(U)--Hydroxiprolin-uts |
| NPU04210 | Urin—Hydroxiprolin/Kreatinin;substanskvot | x10^ -3 | U--Hydroxiprolin/Krea |
| NPU08627 | Plasma—Imipramin+Desipramin;substanskoncentration | nmol/L | S--Imi+Desipramin |
| SWE05073 | Plasma—Immunglobulin A;masskoncentration | g/L | P--Immunglobulin A (mass) |
| NPU02482 | Plasma—Immunglobulin E;arbiträr substanskoncentration(IRP 75/502;procedur) | kIE/L | S--Immunglobulin E |
| SWE05321 | Urin—Immunglobulin G/Kreatinin;arbiträr egenskap(procedur) | g/mol | U--IgG/Krea index |
| SWE05493 | Cerebrospinalvätska—Immunglobulin G;masskoncentration | mg/L | Csv--Immunglobulin G(mass) |
| SWE05326 | Urin—Immunglobulin G;masskoncentration | mg/L | U--Immunglobulin G (mass) |
| SWE05067 | Plasma—Immunglobulin G;masskoncentration | g/L | P--Immunglobulin G (mass) |
| SWE05075 | Cerebrospinalvätska—Immunglobulin G;masskoncentration | g/L | Csv--Immunglobulin G (mass) |
| SWE05092 | Urin—Immunglobulin G;masskoncentration | g/L | U--Immunglobulin G (mass) |
| SWE05319 | Urin—Immunglobulin kappakedja/Kreatinin;arbiträr egenskap(procedur) | g/mol | U--Ig Kappa/Krea index |
| SWE05094 | Urin—Immunglobulin kappakedja;masskoncentration | g/L | U--Ig Kappakedja (mass) |
| SWE05324 | Urin—Immunglobulin kappakedja;masskoncentration | mg/L | U--Ig Kappakedja (mass) |
| SWE05320 | Urin—Immunglobulin lambdakedja/Kreatinin;arbiträr egenskap(procedur) | g/mol | U--Ig Lambda/Krea index |
| SWE05325 | Urin—Immunglobulin lambdakedja;masskoncentration | mg/L | U--Ig Lambdakedja (mass) |
| SWE05095 | Urin—Immunglobulin lambdakedja;masskoncentration | g/L | U--Ig Lambdakedja (mass) |
| SWE05069 | Plasma—Immunglobulin M;masskoncentration | g/L | P--Immunglobulin M (mass) |
| SWE05318 | Plasma—Inhibin B;masskoncentration | ng/L | S--Inhibin B |
| NPU20182 | Plasma—Insulin;substanskoncentration | pmol/L | P--Insulin |
| NPU20181 | Plasma(fastande Patient)—Insulin;arbiträr substanskoncentration(IRP 66/304;procedur) | mIE/L | fP--Insulin |
| NPU02496 | Plasma—Insulin;arbiträr substanskoncentration(IRP 66/304;procedur) | mIE/L | P--Insulin |
| NPU02690 | Plasma—Insulinantikropp(Immunglobulin E);arbiträr koncentration(procedur) | | S--Insulinantikropp(IgE) |
| SWE05136 | Plasma—Insulinlik tillväxtfaktor I;masskoncentration | µg/L | S--IGF 1 |
| SWE05154 | Plasma—Insulinlik tillväxtfaktorbindande protein 3;masskoncentration | mg/L | S--IGFBP 3 |
| NPU10471 | Pankreatisk betacell—Insulinsekretion;arbiträrt flöde(glukos oralt;lista;procedur) | | Pt--Insulin-ins(glukos) |
| NPU10663 | Pankreatisk betacell—Insulinsekretion;arbiträrt flöde(glukagon intramuskulärt;lista;procedur) | | Pt--Insulin-ins(gluka) |
| SWE05327 | Njure—Iohexol-clearance;volymflöde | mL/min | Pt--Iohexol-clearance |
| SWE05328 | Njure—Iohexol-clearance;volymflöde(ytkorrigerad) | mL/min | Pt--Iohexol-clear (korr) |
| NPU14229 | Urin—Isoleucin/Kreatinin;substanskvot | x10^ -3 | U--Isoleucin/Kreatinin |
| NPU02510 | Plasma—Isoleucin;substanskoncentration | µmol/L | P--Isoleucin |
| NPU09027 | Cerebrospinalvätska—Isoleucin;substanskoncentration | µmol/L | Csv--Isoleucin |
| NPU04816 | Plasma—Isoniazid;substanskoncentration | µmol/L | S--Isoniazid |
| NPU20005 | Blod—Isopropanol;substanskoncentration | mmol/L | B--Isopropanol |
| NPU08796 | Plasma—Isopropanol;substanskoncentration | mmol/L | S--Isopropanol |
| NPU04191 | Transferrin(Fe-bindningsställe;Plasma)—Järn;substansfraktion | | S--Järnmättnad |
| NPU02508 | Plasma—Järn;substanskoncentration | µmol/L | S--Järn |
| NPU03940 | Urin—Järn;substanskoncentration | µmol/L | U--Järn |
| NPU04132 | Plasma—Järnbindande kapacitet(Fe;fritt);substanskoncentration | µmol/L | P--UIBC |
| NPU04133 | Plasma—Järnbindande kapacitet(total);substanskoncentration | µmol/L | S--TIBC |
| NPU09005 | Urin—Kadmium/Kreatinin;substanskvot | x10^-6 | U--Kadmium/Krea |
| NPU04874 | Blod—Kadmium;substanskoncentration | nmol/L | B--Kadmium |
| NPU01425 | Plasma—Kadmium;substanskoncentration | nmol/L | P--Kadmium |
| NPU01435 | Plasma—Kalcidiol;substanskoncentration | nmol/L | S--25 D-vitamin |
| NPU01439 | Plasma—Kalcitonin;substanskoncentration | pmol/L | S--Kalcitonin |
| NPU10605 | Plasma—Kalcitoningenrelaterad peptid;substanskoncentration | pmol/L | P--CGRP |
| NPU14007 | Urin—Kalcitoningenrelaterad peptid;substanskoncentration | pmol/L | U--CGRP |
| NPU14008 | Patient(Urin)—Kalcitoningenrelaterad peptid;substansflöde | pmol/d | Pt(U)--CGRP-utsöndring |
| NPU10481 | Tyreoidea—Kalcitoninsekretion;arbiträrt flöde(pentagastrin intravenöst;lista;procedur) | | Pt--Kalcitonin-ins(penta) |
| SWE05127 | Plasma(Serum)—Kaliumjon;substanskoncentration | mmol/L | S--Kalium |
| NPU03230 | Plasma—Kaliumjon;substanskoncentration | mmol/L | P--Kalium |
| NPU03229 | Patient(Urin)—Kaliumjon;substansflöde(procedur) | mmol/d | Pt(U)--Kalium-uts |
| NPU08629 | Feces(specifikation)—Kaliumjon;substansinnehåll | mmol/kg | F--Kalium |
| NPU03787 | Urin—Kaliumjon;substanskoncentration | mmol/L | U--Kalium |
| NPU10168 | Dialysvätska(specifikation)—Kaliumjon;substanskoncentration | mmol/L | Dv(spec)--Kalium |
| NPU04622 | Urin—Kannabinoid;substanskoncentration | µmol/L | U--Kannabinoid |
| NPU08957 | Urin—Kannabinoid;arbiträr koncentration(procedur) | | U--Kannabinoid (sållning) |
| NPU04032 | Patient—Kapillärblödning;tid(Ivy) | s | Pt--Kapillärblödning(Ivy) |
| NPU01456 | Patient—Kapillärblödning;tid(Duke) | s | Pt--Kapillärblödning(Duke) |
| NPU08974 | Plasma—Karbamazepin(fritt);substanskoncentration | µmol/L | S--Karbamazepin, fritt |
| NPU01457 | Plasma—Karbamazepin(total);substanskoncentration | µmol/L | S--Karbamazepin, total |
| NPU08964 | Plasma—Karbamazepinepoxid;substanskoncentration | µmol/L | S--Karbamazepin-epoxid |
| NPU09229 | Konkrement(Urin)—Karbonat;arbiträrt innehåll(procedur) | | Konkr(U)--Karbonat |
| SWE05039 | Plasma—Karcinoembryonalt antigen;masskoncentration | µg/L | S--CEA (mass) |
| NPU14202 | Urin—Karnitin/Kreatinin;substanskvot | x10^ -3 | U--Karnitin/Kreatinin |
| NPU01482 | Plasma—Karnitin;substanskoncentration | µmol/L | P--Karnitin |
| NPU01503 | Plasma—Karnosin;substanskoncentration | µmol/L | P--Karnosin |
| NPU03349 | Plasma—Kinidin;substanskoncentration | µmol/L | S--Kinidin |
| NPU01616 | Plasma—Klomipramin;substanskoncentration | nmol/L | S--Klomipramin |
| NPU03933 | Plasma—Klomipramin+Desmetylklomipramin;substanskoncentration | nmol/L | S--Klomipramin+desmetyl- |
| NPU01618 | Plasma—Klonazepam;substanskoncentration | nmol/L | S--Klonazepam |
| NPU04847 | Urin—Klonazepam;arbiträr koncentration(procedur) | | U--Klonazepam (sållning) |
| NPU04086 | Plasma—Klopentixol;substanskoncentration | nmol/L | S--Klopentixol |
| NPU04126 | Svett(specifikation)—Klorid;substanskoncentration(stimulerad;procedur) | mmol/L | Svett--Klorid |
| NPU20039 | Dialysvätska(specifikation)—Klorid;substanskoncentration | mmol/L | Dv(spec)--Klorid |
| NPU01536 | Plasma—Klorid;substanskoncentration | mmol/L | P--Klorid |
| NPU08613 | Urin—Klorid;substanskoncentration | mmol/L | U--Klorid |
| NPU01535 | Patient(Urin)—Klorid;substansflöde(procedur) | mmol/d | Pt(U)--Kloridutsöndring |
| NPU03816 | Feces—Klorid;substansinnehåll | mmol/kg | F--Klorid |
| NPU04818 | Plasma—Klorokin;substanskoncentration | mol/L | S--Klorokin |
| NPU04822 | Plasma—Klorpromazin;substanskoncentration | nmol/L | S--Klorpromazin |
| NPU04114 | Plasma—Klozapin;substanskoncentration | nmol/L | S--Klozapin |
| NPU01678 | Plasma—Koagulation, batroxobin-inducerat;tid(procedur) | s | P--Koagulation batroxobin |
| NPU01679 | Plasma—Koagulation, russelaktivas X-inducerad;tid(procedur) | s | P--dRVVT |
| NPU01683 | Plasma—Koagulation, trombininducerad;tid(procedur) | s | P--Trombintid |
| NPU01684 | Plasma—Koagulation, vävnadsfaktorinducerad;inverterad relativ tid(normal/aktuell;procedur) | | P--Protrombinkomplex |
| NPU01687 | Plasma—Koagulation, vävnadsfaktorinducerad;tid(procedur) | s | P--Enstegs protrombintid |
| NPU01685 | Plasma—Koagulation, vävnadsfaktorinducerad;relativ tid(aktuell/normal;International Normalised Ratio;IRP 67/40;procedur) | | P--Protrombinkomplex(INR) |
| NPU01682 | Plasma—Koagulation, ytinducerad;tid(procedur) | s | P--APT-tid |
| NPU01635 | Plasma—Koagulationsfaktor IX;arbiträr substanskoncentration(koagulation;IS 84/665;procedur) | kIE/L | P--Faktor IX (koag) |
| NPU10405 | Plasma—Koagulationsfaktor IX;arbiträr substanskoncentration(immunologisk;procedur) | x10^3 arb enh/L | P--Faktor IX Ag |
| NPU10585 | Plasma—Koagulationsfaktor IX-antikropp;arbiträr substanskoncentration(koagulation;procedur) | x10^3 arb enh/L | P--Faktor IX ak |
| NPU10402 | Plasma—Koagulationsfaktor V;relativ substanskoncentration(koagulation;aktuell/normal;procedur) | | P--Faktor V |
| NPU01640 | Plasma—Koagulationsfaktor V;arbiträr substanskoncentration(koagulation;procedur) | x10^3 arb enh/L | P--Faktor V (koag) |
| NPU01644 | Plasma—Koagulationsfaktor VII;arbiträr substanskoncentration(koagulation;IS 84/665;procedur) | kIE/L | P--Faktor VII (koag) |
| NPU01645 | Plasma—Koagulationsfaktor VII;arbiträr substanskoncentration(enzymatisk;IS 84/665;procedur) | IE/L | P--Faktor VII (enz) |
| NPU18278 | Plasma—Koagulationsfaktor VIII;arbiträr substanskoncentration(koagulation;IS 97/586;procedur) | kIE/L | P--Faktor VIII (koag) |
| NPU04008 | Plasma—Koagulationsfaktor VIII;arbiträr substanskoncentration(enzymatisk;IS 87/718;procedur) | kIE/L | P--Faktor VIII C |
| NPU01653 | Plasma—Koagulationsfaktor VIII;arbiträr substanskoncentration(immunologisk;IS 91/666;procedur) | kIE/L | P--Faktor VIII (imm) |
| NPU01652 | Plasma—Koagulationsfaktor VIII;arbiträr substanskoncentration(enzymatisk;IS 91/666;procedur) | kIE/L | P--Faktor VIII (enz) |
| NPU18276 | Plasma—Koagulationsfaktor VIII;arbiträr substanskoncentration(enzymatisk;IS 97/586;procedur) | kIE/L | P--Faktor VIII (enz) |
| NPU18277 | Plasma—Koagulationsfaktor VIII;arbiträr substanskoncentration(immunologisk;IS 97/586;procedur) | kIE/L | P--Faktor VIII (imm) |
| NPU04009 | Plasma—Koagulationsfaktor VIII;arbiträr substanskoncentration(immunologisk;IS 87/718;procedur) | kIE/L | P--Faktor VIII Ag |
| NPU10586 | Plasma—Koagulationsfaktor VIII-antikropp;arbiträr substanskoncentration(enzymatisk;procedur) | x10^3 arb enh/L | P--Faktor VIII ak |
| NPU10397 | Plasma—Koagulationsfaktor X;arbiträr substanskoncentration(enzymatisk;IS 94/746;procedur) | kIE/L | P--Faktor X |
| NPU10404 | Plasma—Koagulationsfaktor XI;relativ substanskoncentration(koagulation;aktuell/normal;procedur) | | P--Faktor XI |
| NPU01663 | Plasma—Koagulationsfaktor XI;arbiträr substanskoncentration(koagulation;procedur) | x10^3 arb enh/L | P--Faktor XI (koag) |
| NPU10403 | Plasma—Koagulationsfaktor XII;relativ substanskoncentration(koagulation;aktuell/normal;procedur) | | P--Faktor XII |
| NPU01667 | Plasma—Koagulationsfaktor XII;arbiträr substanskoncentration(koagulation;procedur) | x10^3 arb enh/L | P--Faktor XII (koag) |
| NPU10396 | Plasma—Koagulationsfaktor XIII, aktiverad;relativ substanskoncentration(enzymatisk;aktuell/normal;procedur) | | P--Faktor XIII substrat |
| NPU10395 | Plasma—Koagulationsfaktor XIII;relativ substanskoncentration(enzymatisk;aktuell/normal;procedur) | | P--Faktor XIII elfores |
| NPU10382 | Plasma—Koagulationsfaktor XIII-antikropp;arbiträr substanskoncentration(enzymatisk;procedur) | x10^3 arb enh/L | P--Faktor XIII ak |
| NPU01700 | Plasma—Kobalamin;substanskoncentration | pmol/L | S--Kobalamin |
| NPU01710 | Urin—Kodein;arbiträr koncentration(procedur) | | U--Kodein (sållning) |
| NPU01706 | Urin—Kokain;arbiträr koncentration(procedur) | | U--Kokain (sållning) |
| NPU01472 | Plasma(venöst Blod)—Koldioxid;substanskoncentration | mmol/L | S--Koldioxid |
| NPU12528 | Plasma(kapillärt Blod)—Koldioxid;partialtryck(patient kroppstemperatur) | kPa | P(kB)--pCO2 (Pt temp) |
| NPU12526 | Plasma(arteriellt Blod)—Koldioxid;partialtryck(patient kroppstemperatur) | kPa | P(aB)--pCO2 (Pt temp) |
| NPU12529 | Plasma(venöst Blod)—Koldioxid;partialtryck(patient kroppstemperatur) | kPa | P(vB)--pCO2 (Pt temp) |
| NPU10029 | Plasma(venöst Blod)—Koldioxid;partialtryck(37ºC) | kPa | P(vB)--pCO2 (37°C) |
| NPU12481 | Plasma(kapillärt Blod)—Koldioxid;partialtryck(37ºC) | kPa | P(kB)--pCO2 (37°C) |
| NPU01470 | Plasma(arteriellt Blod)—Koldioxid;partialtryck(37ºC) | kPa | P(aB)--pCO2 (37°C) |
| NPU01567 | Plasma—Kolesterol+ester, i HDL;substanskoncentration | mmol/L | S--HDL-kolesterol |
| NPU10157 | Plasma(fastande Patient)—Kolesterol+ester, i HDL;substanskoncentration | mmol/L | S(fPt)--HDL-kolesterol |
| NPU04146 | Plasma—Kolesterol+ester, i LDL/Kolesterol+ester, i HDL;substanskvot | | S--LDL-kol/HDL-kol (kvot) |
| NPU01568 | Plasma—Kolesterol+ester, i LDL;substanskoncentration | mmol/L | S--LDL-kolesterol |
| NPU10171 | Plasma(fastande Patient)—Kolesterol+ester, i LDL;substanskoncentration | mmol/L | S(fPt)--LDL-kolesterol |
| NPU01566 | Plasma—Kolesterol+ester;substanskoncentration | mmol/L | S--Kolesterol |
| NPU01570 | Plasma—Kolinesteras;katalytisk koncentration(37ºC;procedur) | µkat/L | S--Kolinesteras |
| NPU01473 | Hemoglobin(Fe;Blod)—Kolmonoxidhemoglobin;substansfraktion | | Hb(B)--CO Hb |
| NPU01718 | Plasma—Komplement C1-esterashämmare;arbiträr koncentration(enzymatisk;procedur) | | P--C1 Esterasinhibitor |
| SWE05057 | Plasma—Komplement C3;masskoncentration | g/L | P--Komplement C3 (mass) |
| SWE05058 | Plasma—Komplement C4;masskoncentration | g/L | P--Komplement C4 (mass) |
| NPU08868 | Urin—Konkrementsammansättning;arbiträrt innehåll(lista;procedur) | | U--Konkrement |
| NPU01773 | Plasma—Koppar;substanskoncentration | µmol/L | P--Koppar |
| NPU08976 | Patient(Urin)—Koppar;substansflöde(procedur) | µmol/d | Pt(U)--Koppar-uts |
| NPU01774 | Urin—Koppar;substanskoncentration | µmol/L | U--Koppar |
| NPU01780 | Leukocytprotein—Koproporfyrinogenoxidas;katalytiskt innehåll(37ºC;procedur) | µkat/kg | Lkc prot--KPGO |
| NPU01578 | Plasma—Koriogonadotropin, alfakedja;arbiträr substanskoncentration(IRP 75/569;procedur) | IE/L | S--hCG, alfa |
| NPU10394 | Urin—Koriogonadotropin;arbiträr koncentration(procedur) | | U--hCG (remsa) |
| NPU01572 | Plasma—Koriogonadotropin;arbiträr substanskoncentration(IS 75/537;procedur) | IE/L | S--hCG, intakt |
| NPU01582 | Plasma—Koriogonadotropin+betakedja;arbiträr substanskoncentration(IS 75/537;procedur) | IE/L | S--hCG + betakedja |
| NPU01585 | Plasma—Koriomammotropin;substanskoncentration | nmol/L | S--Placentalaktogen |
| NPU14068 | Plasma(fastande Patient)—Kortikoliberin;substanskoncentration | pmol/L | fP--Kortikoliberin |
| NPU14069 | Urin—Kortikoliberin;substanskoncentration | pmol/L | U--Kortikoliberin |
| NPU14070 | Patient(Urin)—Kortikoliberin;substansflöde | pmol/d | Pt(U)--Kortikoliberin-uts |
| NPU01785 | Plasma—Kortikotropin;substanskoncentration | pmol/L | P--Kortikotropin |
| NPU10482 | Patient—Kortikotropinsekretion;arbiträrt flöde(kortikoliberin intravenöst;lista;procedur) | | Pt--Kortikotrop-ins (CRH) |
| NPU14495 | Patient(Urin)—Kortisol(fritt);substansflöde(procedur) | nmol/d | Pt(U)--Kortisol,fritt-uts |
| NPU01788 | Saliv—Kortisol;substanskoncentration | nmol/L | Saliv--Kortisol |
| NPU04360 | Urin—Kortisol;substanskoncentration | nmol/L | U--Kortisol |
| NPU01787 | Plasma—Kortisol;substanskoncentration | nmol/L | S--Kortisol |
| NPU01786 | Patient(Urin)—Kortisol;substansflöde(procedur) | nmol/d | Pt(U)--Kortisol-uts |
| NPU10555 | Binjurebark—Kortisolsekretion;arbiträrt flöde(kortikotropin intramuskulärt;lista;procedur) | | Pt--Kortisol-ins (ACTH) |
| NPU01792 | Binjurebark—Kortisolsekretion;arbiträrt flöde(dexametason oralt;lista;procedur) | | Pt--Kortisol-ins(dexamet) |
| NPU10530 | Binjurebark—Kortisolsekretion;arbiträrt flöde(metyrapon oralt;lista;procedur) | | Pt--Kortisol-ins (metyra) |
| NPU04998 | Plasma—Kreatinin;substanskoncentration(enzymatisk) | µmol/L | S--Kreatinin (enz) |
| NPU10043 | Dialysvätska(specifikation)—Kreatinin;substanskoncentration | µmol/L | Dv(spec)--Kreatinin |
| NPU18016 | Plasma—Kreatinin;substanskoncentration | µmol/L | S--Kreatinin |
| NPU09102 | Urin—Kreatinin;substanskoncentration | mmol/L | U--Kreatinin |
| NPU01807 | Plasma—Kreatinin;substanskoncentration(Jaffé) | µmol/L | S--Kreatinin (Jaffé) |
| NPU03800 | Patient(Urin)—Kreatinin;substansflöde(procedur) | mmol/d | Pt(U)--Kreatinin-uts |
| NPU01809 | Njure—Kreatininclearance;volymflöde(procedur) | mL/s | Pt--Kreatininclearance |
| NPU14048 | Njure—Kreatininclearance;volymflöde(procedur) | mL/min | Pt--Kreatininclearance |
| NPU18099 | Njure—Kreatininclearance;volymflöde(ytkorrigerad) | mL/min | Pt--Krea-clearance (korr) |
| SWE05106 | Plasma—Kreatinkinas MB;masskoncentration | µg/L | S--Kreatinkinas MB (mass) |
| NPU01798 | Plasma—Kreatinkinas MB+BB;katalytisk koncentration(37ºC;procedur) | µkat/L | S--Kreatinkinas B |
| NPU01796 | Plasma—Kreatinkinas;katalytisk koncentration(37ºC;procedur) | µkat/L | S--Kreatinkinas |
| NPU01805 | Kreatinkinas(Plasma)—Kreatinkinastyp;katalytisk fraktion(lista;37ºC;procedur) | | CK(S)--CK isoenzym |
| NPU04127 | Ledvätska(specifikation)—Kristaller;taxon(procedur) | | Ledv--Kristaller |
| NPU08761 | Urin—Kristaller;arbiträr koncentration(procedur) | | U--Kristaller |
| NPU18640 | Urin—Kristaller;arbiträrt antal(procedur) | arb enh | U--Kristaller (antal) |
| NPU10614 | Plasma—Kromogranin A;arbiträr substanskoncentration(procedur) | arb enh/L | P--Kromogranin A |
| NPU03794 | Patient—Kropp;höjd | m | Pt--Kroppslängd |
| NPU03804 | Patient—Kropp;massa | kg | Pt--Kroppsvikt |
| NPU08676 | Patient—Kropp;temperatur Celcius | °C | Pt--Kroppstemperatur |
| NPU14108 | Plasma—Kryofibrinogen;arbiträr koncentration(procedur) | | P--Kryofibrinogen |
| NPU01816 | Plasma—Kryoglobulin;arbiträr koncentration(procedur) | | S--Kryoglobulin |
| NPU02699 | Blod—Kvicksilver;substanskoncentration | nmol/L | B--Kvicksilver |
| NPU04850 | Feces—Kymotrypsin;arbiträrt innehåll(procedur) | | F--Kymotrypsin |
| NPU01714 | Plasma—Köldagglutinin;arbiträr koncentration(procedur) | | S--Köldagglutinin |
| SWE05081 | Plasma—Könshormonbindande globulin;masskoncentration | mg/L | S--SHBG (mass) |
| NPU03419 | Plasma—Könshormonbindande globulin;substanskoncentration | nmol/L | S--SHBG |
| NPU18325 | Blod—Laktat;substanskoncentration | mmol/L | B--Laktat |
| NPU02545 | Cerebrospinalvätska—Laktat;substanskoncentration | mmol/L | Csv--Laktat |
| NPU03944 | Plasma(venöst Blod)—Laktat;substanskoncentration | mmol/L | P(vB)--Laktat |
| NPU03943 | Plasma(arteriellt Blod)—Laktat;substanskoncentration | mmol/L | P(aB)--Laktat |
| NPU04109 | Laktatdehydrogenas(Plasma)—Laktatdehydrogenas H2M2;katalytisk fraktion(37ºC;procedur) | | LD(S)--LD 3 (frakt) |
| NPU04104 | Plasma—Laktatdehydrogenas H2M2;katalytisk koncentration(37ºC;procedur) | µkat/L | S--LD 3 |
| NPU04103 | Plasma—Laktatdehydrogenas H3M;katalytisk koncentration(37ºC;procedur) | µkat/L | S--LD 2 |
| NPU04108 | Laktatdehydrogenas(Plasma)—Laktatdehydrogenas H3M;katalytisk fraktion(37ºC;procedur) | | LD(S)--LD 2 (frakt) |
| NPU04107 | Laktatdehydrogenas(Plasma)—Laktatdehydrogenas H4;katalytisk fraktion(37ºC;procedur) | | LD(S)--LD 1 (frakt) |
| NPU04102 | Plasma—Laktatdehydrogenas H4;katalytisk koncentration(37ºC;procedur) | µkat/L | S--LD 1 |
| NPU04110 | Laktatdehydrogenas(Plasma)—Laktatdehydrogenas HM3;katalytisk fraktion(37ºC;procedur) | | LD(S)--LD 4 (frakt) |
| NPU04105 | Plasma—Laktatdehydrogenas HM3;katalytisk koncentration(37ºC;procedur) | µkat/L | S--LD 4 |
| NPU04106 | Plasma—Laktatdehydrogenas M4;katalytisk koncentration(37ºC;procedur) | µkat/L | S--LD 5 |
| NPU04111 | Laktatdehydrogenas(Plasma)—Laktatdehydrogenas M4;katalytisk fraktion(37ºC;procedur) | | LD(S)--LD 5 (frakt) |
| NPU02822 | Laktatdehydrogenas(Plasma)—Laktatdehydrogenas typ;katalytisk fraktion(lista;37ºC;procedur) | | LD(S)--LD isoenzym(frakt) |
| NPU02547 | Plasma—Laktatdehydrogenas typ;katalytisk koncentration(lista;37ºC;procedur) | | S--LD isoenzym |
| NPU02546 | Plasma—Laktatdehydrogenas;katalytisk koncentration(37ºC;procedur) | µkat/L | S--Laktatdehydrogenas |
| NPU02542 | Tunntarm—Laktostolerans;arbiträr egenskap(laktos oralt;lista;procedur) | | Tarm--Laktostolerans |
| NPU08732 | Plasma—Lamotrigin;substanskoncentration | µmol/L | S--Lamotrigin |
| NPU18205 | Ledvätska(specifikation)—Ledvätska;färg | | Ledv(spec)-Ledvätska färg |
| NPU14231 | Urin—Leucin/Kreatinin;substanskvot | x10^ -3 | U--Leucin/Kreatinin |
| NPU09028 | Cerebrospinalvätska—Leucin;substanskoncentration | µmol/L | Csv--Leucin |
| NPU02589 | Plasma—Leucin;substanskoncentration | µmol/L | P--Leucin |
| NPU04130 | Plasma—Leukocytantikropp;arbiträr koncentration(procedur) | | S--Leukocyt-ak |
| NPU10763 | Cerebrospinalvätska—Leukocyter(mononukleär);antalskoncentration | x10^6/L | Csv--Leukocyter, mono |
| NPU04851 | Blod—Leukocyter(mononukleär);antalskoncentration | x10^9/L | B--Leukocyter, mono |
| NPU10175 | Leukocyter(Pleuravätska;specifikation)—Leukocyter(mononukleär);antalsfraktion | | Lkc(Pleura)--Lkc, mono |
| NPU10173 | Leukocyter(Ledvätska;specifikation)—Leukocyter(mononukleär);antalsfraktion | | Lkc(Ledv)--Lkc, mono |
| NPU10177 | Leukocyter(Pleuravätska;specifikation)—Leukocyter(polynukleär);antalsfraktion | | Lkc(Pleura)--Lkc, poly |
| NPU04852 | Blod—Leukocyter(polynukleär);antalskoncentration | x10^9/L | B--Leukocyter, poly |
| NPU10774 | Cerebrospinalvätska—Leukocyter(polynukleär);antalskoncentration | x10^6/L | Csv--Leukocyter, poly |
| NPU10174 | Leukocyter(Ledvätska;specifikation)—Leukocyter(polynukleär);antalsfraktion | | Lkc(Ledv)--Lkc, poly |
| NPU18637 | Urin—Leukocyter;arbiträrt antal(procedur) | arb enh | U--Leukocyter (antal) |
| NPU02593 | Blod—Leukocyter;antalskoncentration | x10^9/L | B--Leukocyter |
| NPU02594 | Cerebrospinalvätska—Leukocyter;antalskoncentration | x10^6/L | Csv--Leukocyter |
| NPU08639 | Ledvätska(specifikation)—Leukocyter;antalskoncentration | x10^6/L | Ledv--Leukocyter |
| NPU03987 | Urin—Leukocyter;arbiträr koncentration(procedur) | | U--Leukocyter (remsa) |
| NPU14082 | Ledvätska(specifikation)—Leukocyter;antalskoncentration | x10^9/L | Ledv--Leukocyter |
| NPU04100 | Blod—Leukocyttyp;antalskoncentration(lista;procedur) | | B--Leukocyttyp (diff) |
| NPU18156 | Blod—Leukocyttyp;antalskoncentration(lista;maskinell;procedur) | | B--Leukocyttyp(diff mask) |
| NPU17580 | Blod—Leukocyttyp;antalskoncentration(lista;mikroskopi;procedur) | | B--Leukocyttyp(diff mikr) |
| NPU04853 | Plasma—Levomepromazin;substanskoncentration | nmol/L | S--Levomepromazin |
| NPU02613 | Plasma—Litiumjon;substanskoncentration | mmol/L | S--Litium |
| NPU04854 | Plasma—Lofepramin;substanskoncentration | nmol/L | S--Lofepramin |
| NPU04855 | Plasma—Lorazepam;substanskoncentration | nmol/L | S--Lorazepam |
| NPU02614 | Urin—Lorazepam;arbiträr koncentration(procedur) | | U--Lorazepam (sållning) |
| NPU02616 | Plasma—Lupusantikoagulans;arbiträr koncentration(procedur) | | P--Lupus-antikoagulans |
| NPU04015 | Plasma—Lutropin;arbiträr substanskoncentration(IRP 68/40;procedur) | IE/L | S--Lutropin |
| NPU02618 | Plasma—Lutropin;arbiträr substanskoncentration(IS 80/552;procedur) | IE/L | S--Lutropin |
| NPU10441 | Hypofys—Lutropinsekretion;arbiträrt flöde(gonadorelin intravenöst;lista;procedur) | | Hf--Lutropin-ins (GnRH) |
| NPU04996 | Blod—Lymfoblaster;antalskoncentration | x10^9/L | B--Lymfoblaster |
| NPU03965 | Leukocyter(Blod)—Lymfocyter;antalsfraktion | | Lkc(B)--Lymfocyter |
| NPU02636 | Blod—Lymfocyter;antalskoncentration | x10^9/L | B--Lymfocyter |
| NPU02624 | Lymfocyter(Blod)—Lymfocyttyp;taxon(HLA-A, B, C) | | Lyc(B)--HLA-typ(A B C) |
| NPU02627 | Lymfocyter(Blod)—Lymfocyttyp;taxon(HLA-DR, -DQ) | | Lyc(B)--HLA-typ(DR -DQ) |
| NPU04932 | Urin—Lysergsyredietylamid;arbiträr koncentration(procedur) | | U--LSD (sållning) |
| NPU14233 | Urin—Lysin/Kreatinin;substanskvot | x10^ -3 | U--Lysin/Kreatinin |
| NPU02639 | Plasma—Lysin;substanskoncentration | µmol/L | P--Lysin |
| NPU09029 | Cerebrospinalvätska—Lysin;substanskoncentration | µmol/L | Csv--Lysin |
| SWE05076 | Plasma—Lysozym;masskoncentration | mg/L | S--Lysozym (mass) |
| SWE05078 | Urin—Lysozym;masskoncentration | µg/L | U--Lysozym (mass) |
| NPU03433 | Plasma—Löst substans;molalitet(procedur) | mmol/kg | S--Osmolalitet |
| NPU03434 | Urin—Löst substans;molalitet(procedur) | mmol/kg | U--Osmolalitet |
| NPU03945 | Patient(Urin)—Magnesium(II, total);substansflöde(procedur) | mmol/d | Pt(U)--Magnesium-uts |
| NPU02647 | Plasma—Magnesium(II, total);substanskoncentration | mmol/L | S--Magnesium, total |
| NPU02648 | Urin—Magnesium(II, total);substanskoncentration | mmol/L | U--Magnesium, total |
| NPU09234 | Konkrement(Urin)—Magnesium(II, total);arbiträrt innehåll(procedur) | | Konkr(U)--Magnesium,total |
| NPU10368 | Konkrement(Urin)—Magnesiumammoniumfosfat;arbiträrt innehåll(procedur) | | Konkr(U)--Mg-ammoniumfosf |
| NPU17094 | Blod—Makrocyter;arbiträr koncentration(procedur) | | B--Makrocyter |
| NPU04857 | Plasma—Maprotilin;substanskoncentration | nmol/L | S--Maprotilin |
| NPU02076 | Plasma—Mejeriprodukt-antikropp(Immunglobulin E);arbiträr koncentration(lista;NCCLS/f;procedur) | | S--Mejeriprodukt-ak (IgE) |
| NPU02696 | Plasma—Meprobamat;substanskoncentration | µmol/L | S--Meprobamat |
| NPU02722 | Urin—Metadon;arbiträr koncentration(procedur) | | U--Metadon (sållning) |
| NPU04520 | Urin—Metamfetamin;arbiträr koncentration(procedur) | | U--Metamfetamin(sållning) |
| NPU03978 | Blod—Metamyelocyter;antalskoncentration | x10^9/L | B--Metamyelocyter |
| NPU03977 | Leukocyter(Blod)—Metamyelocyter;antalsfraktion | | Lkc(B)--Metamyelocyter |
| NPU02723 | Plasma—Metanol;substanskoncentration | mmol/L | S--Metanol |
| NPU20007 | Blod—Metanol;substanskoncentration | mmol/L | B--Metanol |
| NPU02725 | Hemoglobin(Fe;Blod)—Methemoglobin(Fe);substansfraktion | | Hb(B)--Methemoglobin |
| NPU14235 | Urin—Metionin/Kreatinin;substanskvot | x10^ -3 | U--Metionin/Kreatinin |
| NPU02726 | Plasma—Metionin;substanskoncentration | µmol/L | P--Metionin |
| NPU09030 | Cerebrospinalvätska—Metionin;substanskoncentration | µmol/L | Csv--Metionin |
| NPU04858 | Plasma—Metoprolol;substanskoncentration | µmol/L | S--Metoprolol |
| NPU02738 | Cerebrospinalvätska—Metotrexat;substanskoncentration | µmol/L | Csv--Metotrexat |
| NPU02739 | Plasma—Metotrexat;substanskoncentration | µmol/L | S--Metotrexat |
| NPU02780 | Plasma—Metylmalonat;substanskoncentration | µmol/L | S--Metylmalonat |
| NPU04859 | Plasma—Mexiletin;substanskoncentration | µmol/L | S--Mexiletin |
| NPU04860 | Plasma—Mianserin;substanskoncentration | nmol/L | S--Mianserin |
| NPU17095 | Blod—Mikrocyter;arbiträr koncentration(procedur) | | B--Mikrocyter |
| NPU14028 | Plasma—Mirtazapin;substanskoncentration | nmol/L | S--Mirtazapin |
| SWE05311 | Plasma—M-komponent(specifikation);masskoncentration(procedur) | g/L | P--M-komponent (mass) |
| NPU02642 | Plasma—M-komponent;taxon(procedur) | | P--M-komponent |
| NPU08953 | Plasma—Moklobemid;substanskoncentration | nmol/L | S--Moklobemid |
| NPU02840 | Blod—Monocyter;antalskoncentration | x10^9/L | B--Monocyter |
| NPU03966 | Leukocyter(Blod)—Monocyter;antalsfraktion | | Lkc(B)--Monocyter |
| NPU03946 | Plasma—Mononukleosreaktion;arbiträr koncentration(procedur) | | S--Mononukleostest |
| NPU08985 | Urin—Morfin;arbiträr koncentration(procedur) | | U--Morfin (sållning) |
| NPU08990 | Urin—Morfin+analog;arbiträr koncentration(procedur) | | U--Opiater(sållning) |
| NPU08961 | Plasma—Motilin;substanskoncentration | pmol/L | P--Motilin |
| NPU03970 | Blod—Myeloblaster;antalskoncentration | x10^9/L | B--Myeloblaster |
| NPU03976 | Blod—Myelocyter;antalskoncentration | x10^9/L | B--Myelocyter |
| NPU03975 | Leukocyter(Blod)—Myelocyter;antalsfraktion | | Lkc(B)--Myelocyter |
| NPU17173 | Plasma—Mykofenolat;substanskoncentration | µmol/L | P--Mykofenolat |
| SWE05301 | Patient(Urin)—Myoglobin;massflöde(procedur) | µg/d | Pt(U)--Myoglobin-uts |
| NPU09016 | Urin—Myoglobin;arbiträr koncentration(procedur) | | U--Myoglobin |
| SWE05080 | Plasma—Myoglobin;masskoncentration | µg/L | S--Myoglobin (mass) |
| NPU02830 | Plasma—Mögelsvamp-antikropp(Immunglobulin E);arbiträr koncentration(lista;NCCLS/m;procedur) | | S--Mögel-ak (IgE) |
| NPU08766 | Urin—Narkotika;arbiträr koncentration(lista;procedur) | | U--Narkotika(sålln,lista) |
| NPU10192 | Dialysvätska(specifikation)—Natriumjon;substanskoncentration | mmol/L | Dv(spec)--Natrium |
| NPU03431 | Urin—Natriumjon;substanskoncentration | mmol/L | U--Natrium |
| NPU03429 | Plasma—Natriumjon;substanskoncentration | mmol/L | S--Natrium |
| NPU03796 | Patient(Urin)—Natriumjon;substansflöde(procedur) | mmol/d | Pt(U)--Natrium-uts |
| NPU08649 | Feces(specifikation)—Natriumjon;substansinnehåll | mmol/kg | F--Natrium |
| NPU03430 | Svett(specifikation)—Natriumjon;substanskoncentration | mmol/L | Svett--Natrium |
| NPU14029 | Plasma—Nefazodon;substanskoncentration | nmol/L | S--Nefazodon |
| NPU12998 | Plasma—Neuron-specifikt enolas;arbiträr substanskoncentration(procedur) | arb enh/L | S--Neuron-spec enolas |
| NPU14024 | Plasma(fastande Patient)—Neuropeptid K;substanskoncentration | pmol/L | fP--Neuropeptid K |
| NPU14025 | Urin—Neuropeptid K;substanskoncentration | pmol/L | U--Neuropeptid K |
| NPU14026 | Patient(Urin)—Neuropeptid K;substansflöde | pmol/d | Pt(U)--Neuropeptid K-uts |
| NPU10616 | Plasma—Neuropeptid Y;substanskoncentration | pmol/L | P--Neuropeptid Y |
| NPU14019 | Urin—Neuropeptid Y;substanskoncentration | pmol/L | U--Neuropeptid Y |
| NPU14020 | Patient(Urin)—Neuropeptid Y;substansflöde | pmol/d | Pt(U)--Neuropeptid Y-uts |
| NPU14021 | Plasma(fastande Patient)—Neurotensin;substanskoncentration | pmol/L | P(fPt)--Neurotensin |
| NPU14022 | Urin—Neurotensin;substanskoncentration | pmol/L | U--Neurotensin |
| NPU14023 | Patient(Urin)—Neurotensin;substansflöde | pmol/d | Pt(U)--Neurotensin-uts |
| NPU03981 | Leukocyter(Blod)—Neutrofila granulocyter(segmenterad);antalsfraktion | | Lkc(B)--Neutrof gran(seg) |
| NPU03982 | Blod—Neutrofila granulocyter(segmenterad);antalskoncentration | x10^9/L | B--Neutrofila gran (seg) |
| NPU03979 | Leukocyter(Blod)—Neutrofila granulocyter(stavformig);antalsfraktion | | Lkc(B)--Neutrof gr (stav) |
| NPU03980 | Blod—Neutrofila granulocyter(stavformig);antalskoncentration | x10^9/L | B--Neutrofila gran (stav) |
| NPU02902 | Blod—Neutrofila granulocyter;antalskoncentration | x10^9/L | B--Neutrofila granulocyter |
| NPU03983 | Leukocyter(Blod)—Neutrofila granulocyter;antalsfraktion | | Lkc(B)--Neutrofila gran |
| NPU02915 | Plasma—Nitrazepam;substanskoncentration | nmol/L | S--Nitrazepam |
| NPU02916 | Urin—Nitrazepam;arbiträr koncentration(procedur) | | U--Nitrazepam (sållning) |
| NPU04861 | Plasma—Noradrenalin;substanskoncentration | nmol/L | P--Noradrenalin |
| NPU03950 | Patient(Urin)—Noradrenalin;substansflöde(procedur) | nmol/d | Pt(U)--Noradrenalin-uts |
| NPU03949 | Urin—Noradrenalin;substanskoncentration | nmol/L | U--Noradrenalin |
| NPU02923 | Plasma—Nortriptylin;substanskoncentration | nmol/L | S--Nortriptylin |
| NPU02082 | Plasma—Nöt-antikropp(Immunglobulin E);arbiträr koncentration(lista;NCCLS/f;procedur) | | S--Nöt-ak (IgE) |
| NPU09358 | Plasma—Olanzapin;substanskoncentration | nmol/L | S--Olanzapin |
| NPU14240 | Urin—Ornitin/Kreatinin;substanskvot | x10^ -3 | U--Ornitin/Kreatinin |
| NPU09031 | Cerebrospinalvätska—Ornitin;substanskoncentration | µmol/L | Csv--Ornitin |
| NPU02936 | Plasma—Ornitin;substanskoncentration | µmol/L | P--Ornitin |
| SWE05085 | Plasma—Orosomukoid;masskoncentration | g/L | P--Orosomukoid (mass) |
| NPU18378 | Erytrocyter(Blod)—Osmotisk tryckreaktion;arbiträr egenskap(fritt Hemoglobin/allt Hemoglobin 0,5, pH 7,40, 0 h;procedur) | arb enh | Erc(B)--Osmotisk frag(0h) |
| NPU02967 | Erytrocyter(Blod)—Osmotisk tryckreaktion;arbiträr egenskap(fritt Hemoglobin/allt Hemoglobin 0,5, 37°C, pH 7,40, 24 h;procedur) | arb enh | Erc(B)--Osmot frag (24h) |
| SWE05084 | Plasma—Osteokalcin;masskoncentration | µg/L | P--Osteokalcin |
| NPU02971 | Urin—Oxalat;substanskoncentration | µmol/L | U--Oxalat |
| NPU09231 | Konkrement(Urin)—Oxalat;arbiträrt innehåll(procedur) | | Konkr(U)--Oxalat |
| NPU03951 | Patient(Urin)—Oxalat;substansflöde(procedur) | µmol/d | Pt(U)--Oxalat-uts |
| NPU04862 | Plasma—Oxazepam;substanskoncentration | µmol/L | S--Oxazepam |
| NPU02975 | Urin—Oxazepam;arbiträr koncentration(procedur) | | U--Oxazepam (sållning) |
| NPU10265 | Hemoglobin(Fe;total;venöst Blod)—Oxihemoglobin(Fe);substansfraktion | | Hb(vB)--Oxihemoglobin |
| NPU03013 | Hemoglobin(Fe;total;arteriellt Blod)—Oxihemoglobin(Fe);substansfraktion | | Hb(aB)--Oxihemoglobin |
| NPU10754 | Hemoglobin(Fe;total;kapillärt Blod)—Oxihemoglobin(Fe);substansfraktion | | Hb(kB)--Oxihemoglobin |
| NPU03902 | Plasma—Oxkarbazepin;substanskoncentration | µmol/L | S--Oxkarbazepin |
| NPU03011 | Hemoglobin(Fe;O2-bindande;arteriellt Blod)—Oxygen(O2);mättnad | | Hb(aB)--Syrgasmättnad |
| NPU12501 | Plasma(venöst Blod)—Oxygen(O2);partialtryck(37ºC) | kPa | P(vB)--pO2 (37°C) |
| NPU12500 | Plasma(kapillärt Blod)—Oxygen(O2);partialtryck(37ºC) | kPa | P(kB)--pO2 (37°C) |
| NPU08977 | Plasma(arteriellt Blod)—Oxygen(O2);partialtryck(37ºC) | kPa | P(aB)--pO2 (37°C) |
| NPU18398 | Plasma(kapillärt Blod)—Oxygen(O2);partialtryck(patient kroppstemperatur) | kPa | P(kB)--pO2 (Pt temp) |
| NPU14104 | Plasma(arteriellt Blod)—Oxygen(O2);partialtryck(patient kroppstemperatur) | kPa | P(aB)--pO2 (Pt temp) |
| NPU18399 | Plasma(venöst Blod)—Oxygen(O2);partialtryck(patient kroppstemperatur) | kPa | P(vB)--pO2 (Pt temp) |
| NPU16403 | Plasma—Pankreas ö-cell(IA-2)-antikropp;arbiträr substanskoncentration(procedur) | x10^3 arb enh/L | P--Ö-cell(IA-2)-antikropp |
| NPU14539 | Plasma—Pankreas ö-cell(ICA)-antikropp;arbiträr koncentration(procedur) | | P--Ö-cell(ICA)-antikropp |
| NPU14027 | Plasma(fastande Patient)—Pankreastatin;substanskoncentration | pmol/L | P(fPt)--Pankreastatin |
| NPU02509 | Plasma—Pankreatisk beta-cellantikropp;arbiträr koncentration(procedur) | | P--Ö-cells-antikropp |
| NPU03021 | Plasma—Pankreatisk polypeptid;substanskoncentration | pmol/L | P--Pankreatisk polypeptid |
| NPU14011 | Urin—Pankreatisk polypeptid;substanskoncentration | pmol/L | U--Pankreatisk polypeptid |
| NPU14012 | Patient(Urin)—Pankreatisk polypeptid;substansflöde | pmol/d | Pt(U)--Pankr polypept-uts |
| NPU03024 | Plasma—Paracetamol;substanskoncentration | µmol/L | S--Paracetamol |
| NPU03028 | Plasma—Paratyrin;substanskoncentration | pmol/L | P--Paratyrin |
| NPU04863 | Plasma—Paroxetin;substanskoncentration | nmol/L | S--Paroxetin |
| NPU04222 | Urin—Partikeltyp;arbiträr koncentration(lista;procedur) | | U--Sediment |
| NPU03043 | Plasma—Pepsinogen A;arbiträr koncentration(procedur) | | S--Pepsinogen A |
| NPU10613 | Plasma—Peptid Y Y;substanskoncentration | pmol/L | P--Peptid YY |
| NPU03047 | Plasma—Perfenazin;substanskoncentration | nmol/L | S--Perfenazin |
| NPU04708 | Blod—Plasmaceller;antalskoncentration | x10^9/L | B--Plasmaceller |
| NPU03179 | Plasma—Plasminhämmare;arbiträr substanskoncentration(enzymatisk;procedur) | arb enh/L | P--Plasminhämmare (enz) |
| NPU03180 | Plasma—Plasminhämmare;arbiträr substanskoncentration(immunologisk;procedur) | arb enh/L | P--Plasminhämmare (imm) |
| NPU03183 | Plasma—Plasminogen;arbiträr substanskoncentration(enzymatisk;procedur) | x10^3 arb enh/L | P--Plasminogen (enz) |
| NPU03185 | Plasma—Plasminogenaktivatorhämmare 1;arbiträr substanskoncentration(enzymatisk;procedur) | arb enh/L | P--PAI 1 |
| NPU17418 | Plasma—Plasminogenaktivatorhämmare 1;arbiträr substanskoncentration(enzymatisk;procedur) | x10^3 arb enh/L | P--PAI 1 |
| NPU04864 | Urin—Porfobilinogen;arbiträr koncentration(procedur) | | U--Porfobilinogen |
| NPU10202 | Erytrocyter(Blod)—Porfobilinogendeaminas;katalytisk koncentration(37ºC;procedur) | nkat/L | Erc(B)--PBGD |
| NPU09099 | Urin—Porfyrin/Kreatinin;substanskvot | x10^ -3 | U--Porfyrin/Krea |
| NPU10604 | Erytrocyter(Blod)—Porfyrin;substanskoncentration | µmol/L | Erc(B)--Porfyrin |
| NPU03227 | Feces—Porfyrin;arbiträrt innehåll(procedur) | | F--Porfyrin, total |
| NPU03957 | Urin—Porfyrin;arbiträr koncentration(procedur) | | U--Porfyrin (kval) |
| NPU03234 | Patient(Urin)—Pregnantriol;substansflöde(procedur) | µmol/d | Pt(U)--Pregnantriol-uts |
| NPU03235 | Plasma—Primidon;substanskoncentration | µmol/L | S--Primidon |
| NPU03242 | Plasma—Progesteron;substanskoncentration | nmol/L | S--Progesteron |
| NPU08978 | Patient(Urin)—Proinsulin C-peptid;substansflöde(procedur) | nmol/d | Pt(U)--C-peptid-uts |
| NPU04149 | Plasma(fastande Patient)—Proinsulin C-peptid;substanskoncentration | nmol/L | P(fPt)--C-peptid |
| NPU10393 | Pankreatisk betacell—Proinsulin C-peptidsekretion;arbiträrt flöde(glukagon intravenöst;lista;procedur) | | Pt--Proins-C-pep-ins(glu) |
| NPU04020 | Plasma—Proinsulin;substanskoncentration | pmol/L | S--Proinsulin |
| NPU03241 | Plasma—Prokainamid;substanskoncentration | µmol/L | S--Prokainamid |
| SWE05132 | Plasma—Prolaktin;masskoncentration | µg/L | P--Prolaktin |
| SWE05305 | Plasma—Prolaktin;masskoncentration(90 minuter efter stimulering) | µg/L | P--Prolaktin (90 min) |
| SWE05141 | Plasma—Prolaktin;masskoncentration(60 minuter efter stimulering) | µg/L | P--Prolaktin (60 min) |
| SWE05142 | Plasma—Prolaktin;masskoncentration(20 minuter efter stimulering) | µg/L | P--Prolaktin (20 min) |
| SWE05144 | Plasma—Prolaktin;masskoncentration(120 minuter efter stimulering) | µg/L | P--Prolaktin (120 min) |
| SWE05146 | Plasma—Prolaktin;masskoncentration(240 minuter efter stimulering) | µg/L | P--Prolaktin (240 min) |
| SWE05147 | Plasma—Prolaktin;masskoncentration(360 minuter efter stimulering) | µg/L | P--Prolaktin (360 min) |
| SWE05140 | Plasma—Prolaktin;masskoncentration(30 minuter efter stimulering) | µg/L | P--Prolaktin (30min) |
| SWE05304 | Plasma—Prolaktin;masskoncentration(45 minuter efter stimulering) | µg/L | P--Prolaktin (45 min) |
| SWE05139 | Plasma—Prolaktin;masskoncentration(0 minuter efter stimulering) | µg/L | P--Prolaktin (0 min) |
| SWE05303 | Plasma—Prolaktin;masskoncentration(15 minuter efter stimulering) | µg/L | P--Prolaktin (15 min) |
| SWE05138 | Hypofys—Prolaktinsekretion;arbiträrt flöde(protirelin intravenöst;lista;procedur) | | Hf--Prolaktin-ins (TRH) |
| SWE05148 | Hypofys—Prolaktinsekretion;arbiträrt flöde(oktreotid subkutant;lista;procedur) | | Hf--Prolaktin-ins(oktreo) |
| NPU14245 | Urin—Prolin/Kreatinin;substanskvot | x10^ -3 | U--Prolin/Kreatinin |
| NPU03255 | Cerebrospinalvätska—Prolin;substanskoncentration | µmol/L | Csv--Prolin |
| NPU03256 | Plasma—Prolin;substanskoncentration | µmol/L | P--Prolin |
| NPU03974 | Blod—Promyelocyter;antalskoncentration | x10^9/L | B--Promyelocyter |
| NPU03973 | Leukocyter(Blod)—Promyelocyter;antalsfraktion | | Lkc(B)--Promyelocyter |
| SWE05317 | Prostataspecifikt antigen(Plasma)—Prostataspecifikt antigen(fritt);massfraktion | | PSA(S)--PSA,fritt(frakt) |
| SWE05479 | Plasma—Prostataspecifikt antigen(fritt);masskoncentration | µg/L | S--PSA, fritt |
| SWE05089 | Plasma—Prostataspecifikt antigen(total);masskoncentration | µg/L | S--PSA, total |
| NPU14325 | Plasma—Protein C(aktiverat) resistens;relativ tid(förtunnat med plasma utan faktor V;med/utan exogent aktiverat protein C;procedur) | | P--APC-res-kvot F V spec |
| NPU14322 | Plasma—Protein C(aktiverat) resistens;relativ tid(med/utan exogent aktiverat protein C;procedur) | | P--APC-resistens-kvot |
| NPU03281 | Plasma—Protein C;arbiträr substanskoncentration(enzymatisk;IS 86/622;procedur) | kIE/L | P--Protein C (enz) |
| NPU10579 | Plasma—Protein S(fritt);arbiträr substanskoncentration(immunologisk;procedur) | x10^3 arb enh/L | P--Protein S, fritt |
| NPU14577 | Plasma—Protein S(fritt);arbiträr substanskoncentration(ligand;IS 93/590;procedur) | kIE/L | P--Protein S, fritt (lig) |
| NPU14436 | Plasma—Protein S(fritt);arbiträr substanskoncentration(immunologisk;IS 93/590;procedur) | kIE/L | P--Protein S, fritt (imm) |
| NPU14578 | Plasma—Protein S(total);arbiträr substanskoncentration(immunologisk;IS 93/590;procedur) | kIE/L | P--Protein S, total (imm) |
| NPU10580 | Plasma—Protein S(total);arbiträr substanskoncentration(immunologisk;procedur) | x10^3 arb enh/L | P--Protein S, total |
| NPU03276 | Cerebrospinalvätska—Protein;masskoncentration | g/L | Csv--Protein (mass) |
| NPU03278 | Plasma—Protein;masskoncentration | g/L | P--Protein (mass) |
| NPU08670 | Pleuravätska(specifikation)—Protein;masskoncentration | g/L | Pleura--Protein (mass) |
| NPU03958 | Urin—Protein;masskoncentration | g/L | U--Protein (mass) |
| NPU08671 | Ascites—Protein;masskoncentration | g/L | Asc--Protein (mass) |
| NPU04206 | Urin—Protein;arbiträr koncentration(procedur) | | U--Protein (remsa) |
| NPU08672 | Ledvätska(specifikation)—Protein;masskoncentration | g/L | Ledv(spec)--Protein |
| SWE05131 | Plasma(Serum)—Protein;masskoncentration | g/L | S--Protein (mass) |
| SWE05307 | Urin—Proteintyp;masskoncentration(lista;procedur) | | U--Proteinfraktioner |
| SWE05312 | Cerebrospinalvätska—Proteintyp;masskoncentration(lista;procedur) | | Csv--Proteinfraktioner |
| SWE05302 | Plasma—Proteintyp;masskoncentration(lista;procedur) | | P--Proteinfraktioner |
| NPU04866 | Leukocytprotein—Protoporfyrinogenoxidas;katalytisk koncentration(37ºC;procedur) | kat/L | Lkc prot--PPGO |
| NPU04867 | Plasma—Protriptylin;substanskoncentration | nmol/L | S--Protriptylin |
| NPU17702 | Plasma—Protrombin;arbiträr substanskoncentration(koagulation;IS 94/746;procedur) | kIE/L | P--Protrombin (koag) |
| NPU10398 | Plasma—Protrombinfragment 1+2;substanskoncentration(immunologisk;procedur) | nmol/L | P--Protrombinfragment 1+2 |
| NPU10612 | Plasma—Pyridoxal-5-fosfat;substanskoncentration | nmol/L | P--Pyridoxal-5-fosfat |
| NPU03340 | Erytrocyter(Blod)—Pyruvatkinas;entitisk katalytisk aktivitet(37ºC;procedur) | akat | Erc(B)--Pyruvatkinas |
| NPU04119 | Plasma—Remoxiprid;substanskoncentration | µmol/L | S--Remoxiprid |
| SWE05126 | Plasma—Renin;arbiträr katalytisk aktivitet | | P--Renin |
| NPU03351 | Plasma—Renin;arbiträr substanskoncentration(IRP 68/356;procedur) | mIE/L | P--Renin |
| NPU03356 | Erytrocyter(Blod)—Retikulocyter;antalsfraktion | x10^ -3 | Erc(B)--Retikulocyter |
| SWE05316 | Erytrocyter(Blod)—Retikulocyter;antalsfraktion | x10^-2 | Erc(B)--Retikulocyter |
| NPU08694 | Blod—Retikulocyter;antalskoncentration | x10^9/L | B--Retikulocyter |
| NPU03357 | Plasma—Retinol;substanskoncentration | µmol/L | S--Retinol |
| SWE05079 | Plasma—Retinolbindande protein;masskoncentration | mg/L | P--RBP (mass) |
| NPU04868 | Plasma—Risperidon;substanskoncentration | nmol/L | S--Risperidon |
| NPU03383 | Plasma—Salicylat;substanskoncentration | mmol/L | S--Salicylat |
| NPU03396 | Plasma—Sarkosin;substanskoncentration | µmol/L | P--Sarkosin |
| NPU03404 | Blod—Sedimentation;längd(procedur) | mm | B--SR |
| SWE05117 | Blod(kapillärt Blod)—Sedimentation;längd(procedur) | mm | kB--SR (mikro) |
| NPU04156 | Plasma—Selen;substanskoncentration | µmol/L | P--Selen |
| NPU14249 | Urin—Serin/Kreatinin;substanskvot | x10^ -3 | U--Serin/Kreatinin |
| NPU03415 | Plasma—Serin;substanskoncentration | µmol/L | P--Serin |
| NPU03414 | Cerebrospinalvätska—Serin;substanskoncentration | µmol/L | Csv--Serin |
| NPU09364 | Plasma—Sertralin;substanskoncentration | nmol/L | S--Sertralin |
| NPU02085 | Plasma—Skaldjur-antikropp(Immunglobulin E);arbiträr koncentration(lista;NCCLS/f;procedur) | | S--Skaldjur-ak (IgE) |
| NPU14013 | Urin—Somatostatin;substanskoncentration | pmol/L | U--Somatostatin |
| NPU14014 | Patient(Urin)—Somatostatin;substansflöde | pmol/d | Pt(U)--Somatostatin-uts |
| NPU03435 | Plasma—Somatostatin;substanskoncentration | pmol/L | P--Somatostatin |
| NPU03436 | Plasma—Somatotropin;arbiträr substanskoncentration(IS 80/505;procedur) | mIE/L | S--Somatotropin |
| NPU10346 | Hypofys—Somatotropinsekretion;arbiträrt flöde(klonidin oralt;lista;procedur) | | Hf--Somatotropin-ins(klo) |
| NPU03439 | Hypofys—Somatotropinsekretion;arbiträrt flöde(glukos oralt;lista;procedur) | | Hf--Somatotropin-ins(glu) |
| NPU03438 | Hypofys—Somatotropinsekretion;arbiträrt flöde(insulin intravenöst;lista;procedur) | | Hf--Somatotropin-ins(ins) |
| NPU10654 | Hypofys—Somatotropinsekretion;arbiträrt flöde(arginin+insulin intravenöst;lista;procedur) | | Hf--Somatotr-ins(arg+ins) |
| NPU10640 | Hypofys—Somatotropinsekretion;arbiträrt flöde(oktreotid subkutant;lista;procedur) | | Hf--Somatotropin-ins(okt) |
| NPU10349 | Hypofys—Somatotropinsekretion;arbiträrt flöde(protirelin intravenöst;lista;procedur) | | Hf--Somatotropin-ins(TRH) |
| NPU04628 | Plasma—Sotalol;substanskoncentration | µmol/L | P--Sotalol |
| NPU03447 | Seminalplasma—Spermatozoal antikropp;arbiträr koncentration(Immunobead test;procedur) | | SemP--Spermie-ak |
| NPU03446 | Plasma(Blod)—Spermatozoal antikropp;arbiträr koncentration(procedur) | | S--Spermie-ak |
| NPU03455 | Sädesvätska—Spermatozoer;antalskoncentration | x10^9/L | Sem--Spermier |
| NPU18199 | Sädesvätska—Spermatozoer;arbiträr antalskoncentration(procedur) | | Sem--Spermier |
| NPU14015 | Urin—Substans P;substanskoncentration | pmol/L | U--Substans P |
| NPU14016 | Patient(Urin)—Substans P;substansflöde | pmol/d | Pt(U)--Substans P-uts |
| NPU03498 | Plasma—Substans P;substanskoncentration | pmol/L | P--Substans P |
| NPU10210 | Plasma—Sulfametoxazol;substanskoncentration | µmol/L | S--Sulfametoxazol |
| NPU01065 | Plasma—Surt fosfatas, prostatatyp;katalytisk koncentration(37ºC;procedur) | µkat/L | S--Sura fosfataser |
| NPU10755 | Patient(venöst Blod)—Syrabas-status;arbiträr egenskap(lista;procedur) | | Pt(vB)--Syrabas-status |
| NPU04197 | Patient(arteriellt Blod)—Syrabas-status;arbiträr egenskap(lista;procedur) | | Pt(aB)--Syrabas-status |
| NPU03412 | Patient—Sädesvätska;volym | mL | Pt--Sädesvätska, volym |
| NPU14251 | Urin—Taurin/Kreatinin;substanskvot | x10^ -3 | U--Taurin/Kreatinin |
| NPU03540 | Cerebrospinalvätska—Taurin;substanskoncentration | µmol/L | Csv--Taurin |
| NPU03541 | Plasma—Taurin;substanskoncentration | µmol/L | P--Taurin |
| NPU03554 | Plasma—Teofyllin;substanskoncentration | µmol/L | S--Teofyllin |
| NPU03549 | Plasma—Testosteron(fritt);substanskoncentration | nmol/L | S--Testosteron, fritt |
| NPU03543 | Plasma—Testosteron(total);substanskoncentration | nmol/L | P--Testosteron, total |
| NPU18893 | Plasma—Testosteron/Könshormonbindande globulin;substanskvot | | S--Testosteron/SHBG kvot |
| NPU03544 | Saliv—Testosteron;substanskoncentration | nmol/L | Saliv--Testosteron |
| NPU08997 | Urin—Tetrahydrokannabinol;arbiträr koncentration(procedur) | | U--THC (sållning) |
| NPU04830 | Plasma—Tiopental;substanskoncentration | µmol/L | S--Tiopental |
| NPU04115 | Plasma—Tioridazin;substanskoncentration | µmol/L | S--Tioridazin |
| NPU03589 | Plasma—Tokoferol;substanskoncentration | µmol/L | S--Tokoferol |
| NPU10000 | Transferrin(Plasma)—Transferrin, kolhydratfattigt;substansfraktion | | Transf(S)--CDT (frakt) |
| NPU10005 | Plasma—Transferrin, kolhydratfattigt;arbiträr substanskoncentration(procedur) | arb enh/L | S--CDT |
| SWE05300 | Plasma—Transferrin;masskoncentration(procedur) | g/L | S--Transferrin (mass) |
| NPU17701 | Plasma—Transferrinreceptor fragment;substanskoncentration | nmol/L | S--Transferrinreceptor |
| SWE05113 | Plasma—Transtyretin;masskoncentration | g/L | P--Transtyretin (mass) |
| NPU14252 | Urin—Treonin/Kreatinin;substanskvot | x10^ -3 | U--Treonin/Kreatinin |
| NPU03557 | Cerebrospinalvätska—Treonin;substanskoncentration | µmol/L | Csv--Treonin |
| NPU03558 | Plasma—Treonin;substanskoncentration | µmol/L | P--Treonin |
| NPU03612 | Plasma—Triacylglycerollipas;katalytisk koncentration(37ºC;procedur) | µkat/L | S--Lipas |
| NPU03616 | Urin—Triazolam;arbiträr koncentration(procedur) | | U--Triazolam (sållning) |
| NPU14177 | Plasma—Tricykliska antidepressiva läkemedel;arbiträr koncentration(procedur) | | S--Tricyklika |
| NPU10006 | Urin—Tricykliska antidepressiva läkemedel;arbiträr koncentration(procedur) | | U--Tricyklika |
| NPU03620 | Plasma(fastande Patient)—Triglycerid;substanskoncentration | mmol/L | S(fPt)--Triglycerid |
| NPU04094 | Plasma—Triglycerid;substanskoncentration | mmol/L | S--Triglycerid |
| NPU03625 | Plasma—Trijodtyronin(fritt);substanskoncentration | pmol/L | S--Trijodtyronin, fritt |
| NPU03624 | Plasma—Trijodtyronin(total);substanskoncentration | nmol/L | S--Trijodtyronin, total |
| NPU08834 | Plasma—Trimetoprim;substanskoncentration | µmol/L | S--Trimetoprim |
| NPU04869 | Plasma—Trimipramin;substanskoncentration | nmol/L | S--Trimipramin |
| NPU03564 | Plasma—Trombocytantikropp;arbiträr substanskoncentration(procedur) | arb enh/L | S--Trombocyt-ak |
| NPU03568 | Blod—Trombocyter;antalskoncentration | x10^9/L | B--Trombocyter |
| NPU03566 | Plasma—Trombocytfaktor 4;arbiträr substanskoncentration(IS 83/505;procedur) | IE/L | P--Trombocytfaktor 4 |
| NPU03567 | Plasma—Trombocytfaktor 4;substanskoncentration | pmol/L | P--Trombocytfaktor 4 |
| SWE05149 | Plasma—Troponin I;masskoncentration | µg/L | S--Troponin I |
| SWE05090 | Plasma—Troponin T;masskoncentration | µg/L | S--Troponin T |
| NPU03897 | Plasma—Trypsin+trypsinogen;substanskoncentration | mol/L | S--Trypsin+trypsinogen |
| NPU03209 | Plasma—Träd- eller busk-pollen-antikropp(Immunglobulin E);arbiträr koncentration(lista;NCCLS/t;procedur) | | S--Träd/buskpoll-ak (IgE) |
| NPU10578 | Plasma—Tymidinkinas;arbiträr katalytisk koncentration(procedur) | arb enh/L | S--Tymidinkinas |
| SWE05134 | Plasma—Tyreoglobulin;masskoncentration | µg/L | S--Tyreoglobulin |
| SWE05135 | Plasma—Tyreoglobulinantikropp;arbiträr koncentration(procedur) | | S--Tyreoglobulin-ak |
| NPU18600 | Plasma—Tyreoglobulinantikropp;arbiträr substanskoncentration(IRP 65/93;procedur) | kIE/L | S--Tyreoglobulin-ak |
| NPU20041 | Plasma—Tyreoideaperoxidas antikropp;arbiträr substanskoncentration(IRP66/387;procedur) | kIE/L | S--Tyreoideaperoxidas-ak |
| NPU12229 | Plasma—Tyreoideaperoxidas antikropp;arbiträr substanskoncentration(procedur) | x10^3 arb enh/L | S--Tyreoideaperoxidas-ak |
| NPU03576 | Plasma—Tyreoideastimulerande immunglobulin;arbiträr koncentration(procedur) | | S--TSI |
| NPU14256 | Urin—Tyrosin/Kreatinin;substanskvot | x10^ -3 | U--Tyrosin/Kreatinin |
| NPU03659 | Plasma—Tyrosin;substanskoncentration | µmol/L | P--Tyrosin |
| NPU09033 | Cerebrospinalvätska—Tyrosin;substanskoncentration | µmol/L | Csv--Tyrosin |
| NPU08717 | Plasma—Tyrotropin;arbiträr substanskoncentration(IRP 80/558;30 minuter efter stimulering;procedur) | mIE/L | S--Tyrotropin (30 min) |
| NPU04202 | Plasma—Tyrotropin;arbiträr substanskoncentration(IRP 80/558;60 minuter efter stimulering;procedur) | mIE/L | S--Tyrotropin (60 min) |
| NPU10347 | Plasma—Tyrotropin;arbiträr substanskoncentration(IRP 80/558;120 minuter efter stimulering) | mIE/L | S--Tyrotropin (120 min) |
| NPU04199 | Plasma—Tyrotropin;arbiträr substanskoncentration(IRP 80/558;0 minuter efter stimulering;procedur) | mIE/L | S--Tyrotropin (0 min) |
| NPU03577 | Plasma—Tyrotropin;arbiträr substanskoncentration(IRP 80/558;procedur) | mIE/L | S--Tyrotropin |
| NPU10374 | Plasma—Tyrotropin;arbiträr substanskoncentration(IRP 80/558;15 minuter efter stimulering;procedur) | mIE/L | S--Tyrotropin (15 min) |
| NPU17888 | Plasma—Tyrotropinreceptorantikropp;arbiträr substanskoncentration(IS 90/672) | IE/L | P--Tyrotropinreceptor-ak |
| NPU04131 | Plasma—Tyrotropinreceptorantikropp;arbiträr koncentration(procedur) | | S--Tyrotropinreceptor-ak |
| NPU04198 | Hypofys—Tyrotropinsekretion;arbiträrt flöde(protirelin intravenöst;lista;procedur) | | Hf--Tyrotropin-ins (TRH) |
| NPU03579 | Plasma—Tyroxin(fritt);substanskoncentration | pmol/L | S--Tyroxin, fritt |
| NPU03578 | Plasma—Tyroxin(total);substanskoncentration | nmol/L | S--Tyroxin, total |
| SWE05133 | Plasma—Tyroxinbindande globulin;masskoncentration | mg/L | S--TBG |
| NPU09356 | Plasma—Urat;substanskoncentration | µmol/L | S--Urat |
| NPU03687 | Patient(Urin)—Urat;substansflöde(procedur) | mmol/d | Pt(U)--Uratutsöndring |
| NPU20040 | Dialysvätska(specifikation)—Urat;substanskoncentration | mmol/L | Dv(spec)--Urat |
| NPU03959 | Urin—Urat;substanskoncentration | mmol/L | U--Urat |
| NPU10369 | Konkrement(Urin)—Urat;arbiträrt innehåll(procedur) | | Konkr(U)--Urat |
| NPU01458 | Patient(Urin)—Urea;substansflöde(procedur) | mmol/d | Pt(U)--Ureautsöndring |
| NPU01459 | Plasma—Urea;substanskoncentration | mmol/L | S--Urea |
| NPU03930 | Urin—Urea;substanskoncentration | mmol/L | U--Urea |
| NPU10026 | Dialysvätska(specifikation)—Urea;substanskoncentration | mmol/L | Dv(spec)--Urea |
| NPU03695 | Patient—Urin;volym(procedur) | mL | Pt--Urin, volym |
| NPU10379 | Patient—Urininsamling;duration | tim | Pt--Urininsamling (tim) |
| NPU10324 | Patient—Urininsamling;duration | min | Pt--Urininsamling (min) |
| NPU10380 | Patient—Urininsamling;duration | d | Pt--Urininsamling (dygn) |
| NPU03697 | Urin—Urobilinogen;arbiträr koncentration(procedur) | | U--Urobilinogen (kval) |
| NPU04871 | Erytrocyter(Blod)—Uroporfyrinogendekarboxilas;entitisk katalytisk aktivitet | kat | Erc(B)--UPGD |
| NPU14257 | Urin—Valin/Kreatinin;substanskvot | x10^ -3 | U--Valin/Kreatinin |
| NPU03733 | Plasma—Valin;substanskoncentration | µmol/L | P--Valin |
| NPU03732 | Cerebrospinalvätska—Valin;substanskoncentration | µmol/L | Csv--Valin |
| NPU03735 | Plasma—Valproat;substanskoncentration | µmol/L | P--Valproat |
| NPU10001 | Patient(Urin)—Vanillinmandelat/Kreatinin;substansflödeskvot(procedur) | x10^ -3 | Pt(U)--VMA/Krea-uts |
| NPU08685 | Urin—Vanillinmandelat;substanskoncentration | µmol/L | U--Vanillinmandelat |
| NPU03739 | Patient(Urin)—Vanillinmandelat;substansflöde(procedur) | µmol/d | Pt(U)--Vanillinmandel-uts |
| NPU14017 | Urin—Vasoaktiv intestinal polypeptid;substanskoncentration | pmol/L | U--VIP |
| NPU14018 | Patient(Urin)—Vasoaktiv intestinal polypeptid;substansflöde | pmol/d | Pt(U)--VIP-utsöndring |
| NPU03743 | Plasma—Vasoaktiv intestinal polypeptid;substanskoncentration | pmol/L | P--VIP |
| NPU14009 | Urin—Vasopressin;substanskoncentration | pmol/L | U--Vasopressin |
| NPU14010 | Patient(Urin)—Vasopressin;substansflöde | pmol/d | Pt(U)--Vasopressin-uts |
| NPU03745 | Plasma—Vasopressin;substanskoncentration | pmol/L | S--Vasopressin |
| NPU09090 | Plasma—Venlafaxin;substanskoncentration | nmol/L | S--Venlafaxin |
| NPU08966 | Plasma—Vigabatrin;substanskoncentration | µmol/L | S--Vigabatrin |
| NPU03748 | Plasma—von Willebrandfaktor;arbiträr substanskoncentration(immunologisk;IS 91/666) | kIE/L | P--vonWillebrand F Ag |
| NPU03749 | Plasma—von Willebrandfaktor;arbiträr substanskoncentration(ristocetin kofaktor aktivitet;IS 91/666;procedur) | kIE/L | P--vonWillebrand F RCoF |
| NPU03751 | Plasma—von Willebrandfaktor-antikropp;arbiträr substanskoncentration(ristocetin kofaktor aktivitet hämmare;procedur) | arb enh/L | P--vW F-ak RCoF (hämm) |
| NPU08691 | Trombocyter(Blod)—von Willebrandfaktor-multimerer;arbiträr koncentration(immunoblotting;procedur) | | Trc--vW F multi (imm) |
| NPU03752 | Plasma—von Willebrandfaktor-multimerer;arbiträr koncentration(immunoblotting;procedur) | | P--vonWillebrand F MS |
| NPU02415 | Urin—Vätejon;pH(procedur) | | U--pH |
| NPU02412 | Plasma(arteriellt Blod)—Vätejon;pH(patient kroppstemperatur) | | P(aB)--pH (Pt temp) |
| NPU12474 | Plasma(arteriellt Blod)—Vätejon;pH(37ºC) | | P(aB)--pH (37°C) |
| NPU12490 | Plasma(kapillärt Blod)—Vätejon;pH(37ºC) | | P(kB)--pH (37°C) |
| NPU03995 | Plasma(venöst Blod)—Vätejon;pH(37ºC) | | P(vB)--pH (37°C) |
| NPU12491 | Plasma(kapillärt Blod)—Vätejon;pH(patient kroppstemperatur) | | P(kB)--pH (Pt temp) |
| NPU14355 | Dialysvätska—Vätejon;pH | | Dv--pH |
| NPU10318 | Feces—Vätejon;pH(procedur) | | F--pH |
| NPU10165 | Dialysvätska(specifikation)—Vätekarbonat;substanskoncentration(aktuell) | mmol/L | Dv--Standardbikarbonat |
| NPU02410 | Plasma—Vätekarbonat;substanskoncentration(pCO2 5,3 kPa, 37 °C) | mmol/L | B--Standardbikarbonat |
| NPU03584 | Plasma—Vävnadspolypeptid antigen;arbiträr koncentration(procedur) | | S--Vävnadspolypep antigen |
| NPU03764 | Tunntarm—Xylostolerans;arbiträr egenskap(D-xylos oralt;lista;procedur) | | Pt--Xylostolerans |
| NPU03770 | Urin—Zink;substanskoncentration | µmol/L | U--Zink |
| NPU03961 | Patient(Urin)—Zink;substansflöde(procedur) | µmol/d | Pt(U)--Zinkutsöndring |
| NPU18020 | Plasma(fastande Patient)—Zink;substanskoncentration | µmol/L | S(fPt)--Zink |
| NPU03769 | Seminalplasma—Zink;substanskoncentration | µmol/L | SemP--Zink |
| NPU03768 | Plasma—Zink;substanskoncentration | µmol/L | S--Zink |
| NPU03962 | Plasma—Zuklopentixol;substanskoncentration | nmol/L | S--Zuklopentixol |
| NPU02077 | Plasma—Ägg-antikropp(Immunglobulin E);arbiträr koncentration(lista;NCCLS/f;procedur) | | S--Ägg-ak (IgE) |
| NPU03208 | Plasma—Örtpollen-antikropp(Immunglobulin E);arbiträr koncentration(lista;NCCLS/w;procedur) | | S--Örtpollen-ak (IgE) |
| NPU09357 | Plasma—Östradiol(total);substanskoncentration | pmol/L | S--Östradiol, total |
| NPU01979 | Plasma—Östriol;substanskoncentration | nmol/L | S--Östriol |
| NPU01982 | Plasma—Östron;substanskoncentration | pmol/L | S--Östron |
Senast ändrad: 2002-06-14
Informationsansvarig: